<?xml version="1.0" ?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.3 20210610//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">elife</journal-id>
<journal-id journal-id-type="publisher-id">eLife</journal-id>
<journal-title-group>
<journal-title>eLife</journal-title>
</journal-title-group>
<issn publication-format="electronic" pub-type="epub">2050-084X</issn>
<publisher>
<publisher-name>eLife Sciences Publications, Ltd</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">107688</article-id>
<article-id pub-id-type="doi">10.7554/eLife.107688</article-id>
<article-id pub-id-type="doi" specific-use="version">10.7554/eLife.107688.2</article-id>
<article-version-alternatives>
<article-version article-version-type="publication-state">reviewed preprint</article-version>
<article-version article-version-type="preprint-version">1.4</article-version>
</article-version-alternatives>
<article-categories><subj-group subj-group-type="heading">
<subject>Structural Biology and Molecular Biophysics</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Ω-Loop mutations control dynamics of the active site by modulating the hydrogen-bonding network in PDC-3 β-lactamase</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Shuang</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mack</surname>
<given-names>Andrew R</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hujer</surname>
<given-names>Andrea M</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="aff" rid="a4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bethel</surname>
<given-names>Christopher R</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bonomo</surname>
<given-names>Robert A</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="aff" rid="a3">3</xref>
<xref ref-type="aff" rid="a4">4</xref>
<xref ref-type="aff" rid="a5">5</xref>
<xref ref-type="aff" rid="a6">6</xref>
<xref ref-type="aff" rid="a7">7</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2650-2925</contrib-id>
<name>
<surname>Haider</surname>
<given-names>Shozeb</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a8">8</xref>
<xref ref-type="aff" rid="a9">9</xref>
<email>shozeb.haider@ucl.ac.uk</email>
</contrib>
<aff id="a1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02jx3x895</institution-id><institution>UCL School of Pharmacy</institution></institution-wrap>, <city>London</city>, <country country="GB">United Kingdom</country></aff>
<aff id="a2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05rsv9s98</institution-id><institution>Research Service, Louis Stokes Cleveland Department of Veterans Affairs Medical Center</institution></institution-wrap>, <city>Cleveland</city>, <country country="US">United States</country></aff>
<aff id="a3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/051fd9666</institution-id><institution>Department of Molecular Biology and Microbiology, Case Western Reserve University School of Medicine</institution></institution-wrap>, <city>Cleveland</city>, <country country="US">United States</country></aff>
<aff id="a4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/051fd9666</institution-id><institution>Department of Medicine, Case Western Reserve University School of Medicine</institution></institution-wrap>, <city>Cleveland</city>, <country country="US">United States</country></aff>
<aff id="a5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05rsv9s98</institution-id><institution>Clinician Scientist Investigator, Louis Stokes Cleveland Department of Veterans Affairs Medical Center</institution></institution-wrap>, <city>Cleveland</city>, <country country="US">United States</country></aff>
<aff id="a6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/051fd9666</institution-id><institution>Departments of Pharmacology, Biochemistry, and Proteomics and Bioinformatics, Case Western Reserve University School of Medicine</institution></institution-wrap>, <city>Cleveland</city>, <country country="US">United States</country></aff>
<aff id="a7"><label>7</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05rsv9s98</institution-id><institution>CWRU-Cleveland VAMC Center for Antimicrobial Resistance and Epidemiology (Case VA CARES)</institution></institution-wrap>, <city>Cleveland</city>, <country country="US">United States</country></aff>
<aff id="a8"><label>8</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04yej8x59</institution-id><institution>University of Tabuk (PFSCBR)</institution></institution-wrap>, <city>Tabuk</city>, <country country="SA">Saudi Arabia</country></aff>
<aff id="a9"><label>9</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02jx3x895</institution-id><institution>UCL Centre for Advanced Research Computing</institution></institution-wrap>, <city>London</city>, <country country="GB">United Kingdom</country></aff>
</contrib-group>
<contrib-group content-type="section">
<contrib contrib-type="editor">
<name>
<surname>Allen</surname>
<given-names>Toby W</given-names>
</name>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-3521-7950</contrib-id><role>Reviewing Editor</role>
<aff>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/04ttjf776</institution-id><institution>RMIT University</institution>
</institution-wrap>
<city>Melbourne</city>
<country country="AU">Australia</country>
</aff>
</contrib>
<contrib contrib-type="senior_editor">
<name>
<surname>Dötsch</surname>
<given-names>Volker</given-names>
</name>
<role>Senior Editor</role>
<aff>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/04cvxnb49</institution-id><institution>Goethe University Frankfurt</institution>
</institution-wrap>
<city>Frankfurt am Main</city>
<country country="DE">Germany</country>
</aff>
</contrib>
</contrib-group>
<author-notes>
<fn fn-type="coi-statement"><p>Competing interests: RAB reports grants from Entasis, Merck, Wockhardt, Shionogi, and Venatorx outside the submitted work. All the other authors have no conflict of interest.</p></fn>
</author-notes>
<pub-date date-type="original-publication" iso-8601-date="2025-09-25">
<day>25</day>
<month>09</month>
<year>2025</year>
</pub-date>
<pub-date date-type="update" iso-8601-date="2025-12-09">
<day>09</day>
<month>12</month>
<year>2025</year>
</pub-date>
<volume>14</volume>
<elocation-id>RP107688</elocation-id>
<history>
<date date-type="sent-for-review" iso-8601-date="2025-06-10">
<day>10</day>
<month>06</month>
<year>2025</year>
</date>
</history>
<pub-history>
<event>
<event-desc>Preprint posted</event-desc>
<date date-type="preprint" iso-8601-date="2025-05-14">
<day>14</day>
<month>05</month>
<year>2025</year>
</date>
<self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2024.02.04.578824"/>
</event>
<event>
<event-desc>Reviewed preprint v1</event-desc>
<date date-type="reviewed-preprint" iso-8601-date="2025-09-25">
<day>25</day>
<month>09</month>
<year>2025</year>
</date>
<self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.107688.1"/>
<self-uri content-type="editor-report" xlink:href="https://doi.org/10.7554/eLife.107688.1.sa2">eLife Assessment</self-uri>
<self-uri content-type="referee-report" xlink:href="https://doi.org/10.7554/eLife.107688.1.sa0">Reviewer #1 (Public review):</self-uri>
<self-uri content-type="referee-report" xlink:href="https://doi.org/10.7554/eLife.107688.1.sa1">Reviewer #1 (Public review):</self-uri>
</event>
</pub-history>
<permissions>
<copyright-statement>© 2025, Chen et al</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Chen et al</copyright-holder>
<ali:free_to_read/>
<license xlink:href="https://creativecommons.org/licenses/by/4.0/">
<ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="elife-preprint-107688-v2.pdf"/>
<abstract>
<p>The expression of antibiotic-inactivating enzymes, such as <italic>Pseudomonas</italic>-derived cephalosporinase-3 (PDC-3), is a major mechanism of intrinsic resistance in bacteria. Using reinforcement learning-driven molecular dynamics simulations and constant pH MD, we investigate how clinically observed mutations in the Ω-loop (at amino acids V211, G214, E219, and Y221) alter the structure and function of PDC-3. Our findings reveal that these substitutions modulate the dynamic flexibility of the Ω-loop and the R2-loop, reshaping the cavity of the active site. In particular, E219K and Y221A disrupt the tridentate hydrogen bond network around K67, thus lowering its <italic>pK</italic><sub><italic>a</italic></sub> and promoting proton transfer to the catalytic residue S64. Markov state models reveal that E219K achieves enhanced catalysis by adopting stable, long-lived ‘active’ conformations, whereas Y221A facilitates activity by rapidly toggling between bond-formed and bond-broken states. In addition, substitutions influence key hydrogen bonds that control the opening and closure of the active-site pocket, consequently influencing the overall size. The pocket expands in all nine clinically identified variants, creating additional space to accommodate bulkier R1 and R2 cephalosporin side chains. Taken together, these results provide a mechanistic basis for how single residue substitutions in the Ω-loop affect catalytic activity. Insights into the structural dynamics of the catalytic site advance our understanding of emerging β-lactamase variants and can inform the rational design of novel inhibitors to combat drug-resistant <italic>P. aeruginosa</italic>.</p>
</abstract>
<funding-group>
<award-group id="funding-1">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/043z4tv69</institution-id>
<institution>National Institute of Allergy and Infectious Diseases</institution>
</institution-wrap>
</funding-source>
<award-id>R01AI063517</award-id>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta specific-use="meta-only">
<meta-name>publishing-route</meta-name>
<meta-value>prc</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<fn-group content-type="summary-of-updates">
<title>Summary of Updates:</title>
<fn fn-type="update"><p>Minor changes in the text on :
Page 4, Line 108-110
Page 6, Line 141-167
Page 8, Line 211-213
Page 10, Line 240-246
Page 10, Line 250-260
Page 14, Line 361
Figure 1D
Figure 3B</p></fn>
</fn-group>
</notes>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p><italic>Pseudomonas aeruginosa</italic> is a ubiquitous Gram-negative bacterium from the family Pseudomon-adaceae (<xref ref-type="bibr" rid="c42">Pang et al., 2019</xref>). This pathogen is commonly found in hospitals and other healthcare settings, where it can cause infections in people who are immunocompromised or have chronic conditions (<xref ref-type="bibr" rid="c26">Kerr and Snelling, 2009</xref>). Pseudomonal infections are associated with high morbidity and mortality in many groups, including patients with cystic fibrosis, pneumonia, and chronic obstructive pulmonary disease (COPD) (<xref ref-type="bibr" rid="c15">Curran et al., 2018</xref>; <xref ref-type="bibr" rid="c25">Jurado-Martin et al., 2021</xref>; <xref ref-type="bibr" rid="c33">Malhotra et al., 2019</xref>; <xref ref-type="bibr" rid="c52">Reynolds and Kollef, 2021</xref>). β-lactam antibiotics, characterized by the presence of a β-lactam ring in their chemical structure, are often the first-line of treatment for bacterial infections as they tend to have fewer side effects and are less toxic than other antibiotics (<xref ref-type="bibr" rid="c38">Mora-Ochomogo and Lohans, 2021</xref>). Mechanistically, β-lactams work by inhibiting the synthesis of the bacterial cell wall, which is necessary for the survival and growth of bacteria (<xref ref-type="bibr" rid="c30">Lima et al., 2020</xref>). β-lactam antibiotics are usually effective against a wide range of bacteria, but can lose their effectiveness if the bacteria develop resistance to them. <italic>P. aeruginosa</italic> is known for its ability to develop resistance to multiple classes of antimicrobial drugs (<xref ref-type="bibr" rid="c22">Horcajada et al., 2019</xref>; <xref ref-type="bibr" rid="c42">Pang et al., 2019</xref>; <xref ref-type="bibr" rid="c61">Spagnolo et al., 2021</xref>). Therefore, the greatest challenge to eradicating <italic>P. aeruginosa</italic> infections are multidrug-resistant (MDR) and extensively drug-resistant (XDR) isolates. The World Health Organization has identified <italic>P. aeruginosa</italic> as a top-priority pathogen for research and development of new antibiotics due to its ability to cause serious infections and its increasing resistance to currently available treatment options (<xref ref-type="bibr" rid="c62">Tacconelli et al., 2018</xref>).</p>
<p>The production of antibiotic-inactivating enzymes is one of the major mechanisms of intrinsic resistance in bacteria (<xref ref-type="bibr" rid="c39">Munita and Arias, 2016</xref>). <italic>P. aeruginosa</italic> can express a class C β-lactamase, named <italic>Pseudomonas</italic>-derived cephalosporinase (PDC), which is an antibiotic-inactivating enzyme (<xref ref-type="bibr" rid="c12">Colque et al., 2022</xref>). PDC-3 is a serine β-lactamase that can inactivate a broad range of β-lactam antibiotics, including penicillins, cephalosporins, monobactams, and carbapenems, by breaking the amide bond of the β-lactam ring through a catalytic site serine (<xref rid="fig1" ref-type="fig">Figure 1A</xref> and <xref rid="fig1" ref-type="fig">B</xref>) (<xref ref-type="bibr" rid="c42">Pang et al., 2019</xref>; <xref ref-type="bibr" rid="c64">Tripathi and Nair, 2013</xref>, <xref ref-type="bibr" rid="c65">2016</xref>). Cephalosporins are known to be highly susceptible to PDC-3 inactivation (<xref ref-type="bibr" rid="c3">Barnes et al., 2018</xref>). The active site of PDC-3 is located at the intersection of the enzyme’s α-helical and α/β domains (<xref rid="fig1" ref-type="fig">Figure 1D</xref>). The active site can be further divided into two distinct regions: the R1 site and the R2 site. These regions are defined by the specific binding interactions they facilitate with the R1 and R2 side chains of the cephalosporins, respectively (<xref rid="fig1" ref-type="fig">Figure 1A</xref>). The R1 site is surrounded by the Ω-loop, while the R2 site is encased by the R2-loop, which is comprised of the α helix H-10. The Ω-loop and the R2-loop are located at opposite ends of the active site, with the catalytic serine residue positioned in the middle (<xref ref-type="bibr" rid="c24">Jacoby, 2009</xref>). However, the Ω-loop and R2-loop, are particularly prone to amino acid substitutions, insertions, and deletions that expand the active site and accommodate larger R1 and R2 groups of the cephalosporins (<xref ref-type="bibr" rid="c40">Nordmann and Mammeri, 2007</xref>). These modifications have been observed to enhance the capacity of the enzyme to hydrolyze a wider range of β-lactam antibiotics (<xref ref-type="bibr" rid="c3">Barnes et al., 2018</xref>). The evolution of PDC-3 β-lactamase and its amino acid variants, which often result in enhanced catalytic activity and expanded-spectrum of cephalosporin hydrolysis, has garnered considerable interest in scientific research (<xref ref-type="bibr" rid="c55">Ruedas-Lopez et al., 2022</xref>). As previously reported, several PDC-3 Ω-loop variants, including V211A, V211G, G214A, G214R, E219A, E219G, E219K, Y221A and Y221H were found in highly drug-resistant <italic>P. aeruginosa</italic> clinical isolates (<xref ref-type="bibr" rid="c3">Barnes et al., 2018</xref>). All residues in this study are numbered based on the Structural alignment-based numbering of class C β-lactamase scheme (SANC) (<xref ref-type="bibr" rid="c31">Mack et al., 2020</xref>).</p>
<fig id="fig1" position="float" fig-type="figure">
<label>Figure 1.</label>
<caption><title>Structures and catalytic mechanism of β-lactam antibiotics and PDC-3 β-lactamase.</title>
<p>(A) Structures of representative β-lactam antibiotics. The notation R (R1/R2) represents the point of addition of functional groups. (B) Structures of commonly used cephalosporins. The R1 side chains of the antibiotics are shown in red, while the R2 side chains are marked in blue. (C) General mechanism of PDC-3 β-lactamase hydrolysis of cephalosporins. (D) The overall structure of the protein is shown in the cartoon representation (PDB ID: 4HEF). The Ω-loop and R2-loop are colored orange and red, respectively. The conserved residues in the active sites are colored green and highlighted as sticks. The positions of all mutations (V211A/G, G214A/R, E219A/G/K and Y221A/H) are highlighted as red spheres.</p></caption>
<graphic xlink:href="578824v4_fig1.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<p>Molecular Dynamics (MD) simulations provide valuable insights into the time-evolved dynamic behavior of biomolecules such as proteins (<xref ref-type="bibr" rid="c21">Hollingsworth and Dror, 2018</xref>). Among various enhanced sampling methods, Adaptive Bandit Molecular Dynamics (AB-MD) stands out as a powerful, reinforcement learning (RL)-based adaptive sampling strategy (<xref ref-type="bibr" rid="c45">Pérez et al., 2020</xref>). Compared to a single long equilibrium MD simulation (which can become trapped in a metastable state) or bias-based enhanced sampling techniques like accelerated MD (aMD) and Gaussian accelerated MD (GaMD) that add boost potentials to smooth the energy landscape and facilitate barrier crossing, AB-MD employs a reinforcement learning-inspired multi-armed bandit to adaptively guide multiple short, unbiased trajectories toward regions of underexplored conformational space (<xref ref-type="bibr" rid="c4">Bhattarai and Miao, 2018</xref>). In a multi-armed bandit, each ‘arm’ yields a reward, and an agent must balance exploration (trying less-sampled options) and exploitation (focusing on the best-known options). AB-MD applies this idea to MD by treating different regions of conformational space (or states) as the bandit ‘arms’. At each iteration, the algorithm decides which state to launch a new MD simulation from, aiming to maximize sampling effciency while still obtaining an accurate, unbiased representation of the system’s equilibrium behavior.</p>
<p>In this study, the AB-MD approach was employed to explore the conformational landscape of PDC-3 and its variants at the atomistic level. Additionally, constant pH MD simulations were performed to examine the protonation-state behavior of key residues in the catalytic site. By analyzing the conformational ensembles and kinetics of PDC-3 through these simulations, the project aimed to uncover underlying mechanisms governing the function of PDC-3 and its variants. Understanding the molecular mechanisms underlying PDC-3 function and the development of resistance is of paramount importance in combating <italic>P. aeruginosa</italic> infections. This knowledge can aid in the development of more effective treatments to combat these bacteria.</p>
</sec>
<sec id="s2">
<title>Results and discussion</title>
<sec id="s2a">
<title>Amino acid substitutions change the lexibility of Ω-loops and R2-loops</title>
<p>To investigate how the mutations in the Ω-loop affect PDC-3 dynamics, adaptive-bandit molecular dynamics (AB-MD) simulations were carried out for each system. 100 trajectories of 300 ns each (totaling 30 µs per system) were run. Both root-mean-square deviation (RMSD) and root-meansquare fluctuations (RMSF) analysis provide insights into the dynamic behavior and structural differences of biomolecules (<xref ref-type="bibr" rid="c34">Martinez, 2015</xref>; <xref ref-type="bibr" rid="c51">Prabantu et al., 2022</xref>). Firstly, the structural stability of the overall conformation of the wild-type PDC-3 and its variants was investigated using pairwise RMSD analysis. The results of the RMSD analysis reveal that the wild-type PDC-3 displays a relatively low degree of structural variability, indicating that the protein maintains a relatively consistent overall conformation over time (<xref rid="fig2" ref-type="fig">Figure 2A</xref> and <xref ref-type="fig" rid="fig2s1">figure Supplement 1</xref>). Similarly, the V211G, G214A, and Y221H variants also exhibit low RMSD values, which suggests that these structures are less flexible. In contrast, the V211A and E219G variants exhibit the highest RMSD values among the set of structures, indicating a high level of structural variability. This implies that these substitutions lead to increased conformational fluctuations in the protein over time. The G214R, E219A, E219K and Y221A variants exhibit RMSD values that are intermediate between the wild-type and the most flexible variants, indicating that these amino acid substitutions have a moderate effect on the structural stability of the protein’s conformation, i.e., not as significant as the V211A and E219G substitutions.</p>
<fig id="fig2" position="float" fig-type="figure">
<label>Figure 2.</label>
<caption><title>Structural stability and dynamic flexibility analyses of wild-type PDC-3 β-lactamase and its variants.</title>
<p>(A) Pairwise Root Mean Square Deviation (RMSD) comparison of wild-type PDC-3 and its variants. The cross correlation matrix shows the RMSD values between each pair of structures. The color intensity represents the RMSD value, with lower values indicating a higher degree of structural similarity between the structures. This visualization can be used to identify patterns and trends in the structural stability of the set of structures and demonstrate the impact of substitutions on the overall conformational stability of the protein. (B) The root-mean-square fluctuation (RMSF) of wild-type PDC-3 and its variants. The Ω-loop (residues G183 to S226) is highlighted in yellow, and the R2-loop (residues L280 to Q310) is highlighted in blue. (C) Core Cα root-mean-square deviation (RMSD) superimposition from PDC-3 and its mutants. The blue parts represent the least mobile Cα atoms (80%) while the red parts highlight the most mobile atoms (20%). <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>. The distribution of RMSD values of the wild-type PDC-3 and its variants. The three violin plots illustrate the RMSD values of the complete protein, the Ω-loop, and the R2-loop, respectively. The width of each violin plot represents the density of data points at a given RMSD value. The median and quartiles are indicated by the white dot and the thick black line inside the violin plot, respectively. The crystal structure PDB ID 4HEF is used as the reference. <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>. RMSD as a function of the fraction of the atoms considered in the alignment.</p></caption>
<graphic xlink:href="578824v4_fig2.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<p>To identify regions that contribute the most to the conformational changes in the wild-type PDC-3 and its variants, the RMSF values of Cα atoms were calculated. High RMSF values indicate a high degree of flexibility or mobility for the corresponding atoms, while low RMSF values indicate a significant degree of rigidity (<xref ref-type="bibr" rid="c5">Boot et al., 2011</xref>). The wild-type PDC-3 and the G214A, G214R, E214G, and Y221A variants exhibit high flexibility in their Ω-loop, as evidenced by the relatively large per-residue RMSF values observed (approximately 4 Å). In contrast, the V211A, V211G, E219K, and Y221H variants display more constrained conformations in the Ω-loop. Notably, the V211A and V211G variants demonstrate the highest stability in the Ω-loop, with average RMSF values around 1.5 Å, whereas the E219K and Y221H variants exhibit intermediate flexibility, with RMSF values averaging between 2 and 2.5 Å. In terms of the R2-loop, wild-type PDC-3 displays a relatively low degree of flexibility while all variants exhibit an increase in structural flexibility. This suggests that these substitutions have a significant impact on the stability of the R2-loop, potentially affecting enzyme function. A detailed observation of the individual variants reveals that the V211A variant exhibits a particularly high degree of flexibility, as evidenced by the comparatively higher RMSF values, followed by the E219G variant. On the other hand, the Y221A and Y221H variants exhibit a relatively lower degree of flexibility, as inferred by the lower RMSF values observed (<xref rid="fig2" ref-type="fig">Figure 2B, C</xref> and <xref ref-type="fig" rid="fig2s2">figure Supplement 2</xref>). Therefore, flexibility of PDC-3 is predominantly localized to the Ω- and R2-loops, whereas the remainder of the structure is comparatively rigid.</p>
<p>The importance of Ω-loop and R2-loop in class C β-lactamases has been previously confirmed (<xref ref-type="bibr" rid="c48">Philippon et al., 2022</xref>). These loops play a crucial role in the binding and activity of the class C β-lactamases (<xref ref-type="bibr" rid="c48">Philippon et al., 2022</xref>). Specifically, residues V211 and Y221 within the Ω-loop have been identified to engage in hydrophobic interactions with the R1 side chains of cephalosporins. The substitution of V211A has been reported to be associated with acquired resistance to cefepime or cefpirome (<xref ref-type="bibr" rid="c53">Rodriguez-Martinez et al., 2010</xref>). Additionally, the characteristic aminothiazole ring found in most third-generation cephalosporins interacts with Y221 in an edge-to-face manner, which represents typical quadrupole-quadrupole interactions. However, Y221 can sometimes create steric clashes that prevent ligands from entering the binding sites (<xref ref-type="bibr" rid="c3">Barnes et al., 2018</xref>; <xref ref-type="bibr" rid="c50">Powers and Shoichet, 2002</xref>). Deletion of Y221 has been observed to broaden substrate specificity and confer resistance to ceftazidime-avibactam (<xref ref-type="bibr" rid="c29">Lahiri et al., 2015</xref>). Moreover, the expanded Ω-loop of P99, another member of class C β-lactamases, exhibits conformational flexibility that may facilitate the hydrolysis of oxyimino β-lactams by making the acyl intermediate more accessible to attack by water (<xref ref-type="bibr" rid="c13">Crichlow et al., 1999</xref>). In terms of the R2-loop, it has been observed that the N289 (N287 in PDC-3) forms hydrogen-bonding interactions with the C4 carboxylate hydrogen bonds directly in the AmpC/13 (moxalactam) complex (<xref ref-type="bibr" rid="c14">Crichlow et al., 2001</xref>). Furthermore, the T289, A292, and L293 residues within the R2-loop of class C β-lactamases have been found to exhibit hydrophobic contacts with the dimethyl group in the R2 chains of cephalosporins (<xref ref-type="bibr" rid="c50">Powers and Shoichet, 2002</xref>). Additional research suggests that the removal of the R2 group in cephalosporins occurs, while the R1 group remains intact (<xref ref-type="bibr" rid="c10">Chaudhry et al., 2019</xref>; <xref ref-type="bibr" rid="c47">Perez-Inestrosa et al., 2005</xref>). This observation indicates that the high flexibility of the R2-loop could be a crucial factor in stabilizing substrates during both the acylation and deacylation steps simultaneously. Overall, the flexibility or mobility of the Ω-loops and R2-loops allows the PDC-3 active site cavity to adopt different size and shapes, thus affecting the binding of different β-lactams and allowing for extended-spectrum activity of some class C β lactamases.</p>
</sec>
<sec id="s2b">
<title>E219K and Y221A mutations facilitate the proton transfer</title>
<p>The substitution of E219 to K219 or Y221 to A221 leads to conformational changes in the active site. Notably, crucial residues S64 and K67 undergo clear conformational alterations. In the E219K substitution, nearly half of the structures display <italic>gauche(-)</italic> (60°) conformations for S64, which is uncommon in the wild-type PDC-3 and other variants. The Y221A variant also shows limited <italic>gauche(-)</italic> (60°) conformations for S64. Regarding K67, <italic>gauche(+)</italic> (-60°) conformations dominate in the wildtype PDC-3 and other variants, but almost 50% of the structures exhibit <italic>trans</italic> (180°) conformations with the E219K variant (<xref rid="fig3" ref-type="fig">Figure 3A</xref>). The conformational changes of S64 and K67 can impact the formation of hydrogen bonds (<xref rid="tbl1" ref-type="table">Table 1</xref> and <xref rid="fig3" ref-type="fig">Figure 3</xref> <xref ref-type="fig" rid="fig3s1">figure Supplement 1</xref>). Specifically, the hydrogen bond formation between K67(NZ) and S64(OG) is observed in most structures of wild-type PDC-3 and variants, but it is broken in most structures with the E219K and Y221A mutants (<xref rid="fig3" ref-type="fig">Figure 3B</xref>). The fractions of formation for this hydrogen bond in E219K and Y221A mutants are only 30.36% and 40.05%, respectively. In addition, the formation of K67(NZ)-N152(OD1) and K67(NZ)-G220(O) interactions are also greatly decreased in the E219K and Y221A variants. This could potentially have implications for the catalytic activity of the enzyme, as S64 is a catalytic residue involved in the acylation step of the β-lactamase. K67 is believed to act as a general base in the acylation step of the β-lactamase catalytic mechanism, abstracting a proton from the hydroxyl group of S64, which in turn facilitates the nucleophilic attack of the β-lactam ring (<xref ref-type="bibr" rid="c64">Tripathi and Nair, 2013</xref>, <xref ref-type="bibr" rid="c65">2016</xref>). Therefore, K67 is thought to toggle between protonated and deprotonated states to facilitate proton transfer in the catalytic cycle (<xref rid="fig1" ref-type="fig">Figure 1B</xref>). However, when K67 is involved in persistent and energetically favored hydrogen bonding interactions with S64, N152, and G220, these stable interactions can lock it in the protonated state. This conformational arrest makes it less available to undergo the protonation state toggling required for catalysis.</p>
<table-wrap id="tbl1" orientation="portrait" position="float">
<label>Table 1.</label>
<caption><title>The fraction (%) of the formation of critical hydrogen bonds in the active sites.</title></caption>
<graphic xlink:href="578824v4_tbl1.tif" mime-subtype="tiff" mimetype="image"/>
</table-wrap>
<fig id="fig3" position="float" fig-type="figure">
<label>Figure 3.</label>
<caption><title>E219K and Y221A mutations reshape the catalytic conformations and protonation states of K67.</title>
<p>(A) Density distribution of the x1 torsion angles of S64 (left) and K67 (right) in wild-type PDC-3 and its variants. (B) Hydrogen bond interactions (dashed lines) between K67(NZ)-S64(OG), K67(NZ)-N152(OD1), and K67(NZ)-G220(O) are formed in wild-type PDC-3 (orange) but broken in the E219K (pink) and Y221A (blue) variants. (C) pH titration curves for K67 based on three replicate constant-pH MD simulations. Each point indicates the fraction of deprotonated K67 at a given pH, and the lines are best fits to a titration model. The estimated <italic>pK</italic><sub><italic>a</italic></sub> values are shown in the legend. <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>. The distance distributions of the tridentate hydrogen-bonding interactions (K67(NZ)-S64(OG), K67(NZ)-N152(OD1) and K67(NZ)-G220(O). Each violin represents the probability density of observed distances, with median and quartiles indicated by the white dot and the thick black line inside the violin plot, respectively. <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>. Time-resolved deprotonation of K67 in WT, E219K, and Y221A over 200-ns constant-pH MD simulations at six pH values (5, 6, 7, 8, 9, 10, and 11). Each panel plots the deprotonated fraction of K67 versus simulation time for one replica.</p></caption>
<graphic xlink:href="578824v4_fig3.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<p>The protonation state (<italic>pK</italic><sub><italic>a</italic></sub>) of K67 in the enzyme is therefore critical: a lowered <italic>pK</italic><sub><italic>a</italic></sub> could allow K67 to exist as a neutral ‘general base’ at physiological pH, ready to accept a proton in catalysis (<xref ref-type="bibr" rid="c11">Chen et al., 2009</xref>). Indeed, analogies from related enzymes suggest that catalytic lysines often have depressed <italic>pK</italic><sub><italic>a</italic></sub> values (e.g. K47 in PBP5 and K73 in TEM-1) to enable catalytic function (<xref ref-type="bibr" rid="c18">Golemi-Kotra et al., 2004</xref>; <xref ref-type="bibr" rid="c66">Zhang et al., 2007</xref>; <xref ref-type="bibr" rid="c60">Shi et al., 2008</xref>; <xref ref-type="bibr" rid="c36">Meroueh et al., 2005</xref>). However, directly measuring or computing the <italic>pK</italic><sub><italic>a</italic></sub> of a buried lysine in a large enzyme is challenging. Constant pH molecular dynamics simulations (CpHMD) provide a powerful <italic>in silico</italic> approach to estimate <italic>pK</italic><sub><italic>a</italic></sub> by allowing protonation states to fluctuate according to a chosen pH (<xref ref-type="bibr" rid="c27">Kim et al., 2015</xref>). Here, we employed CpHMD to compute the <italic>pK</italic><sub><italic>a</italic></sub> of K67 in wild-type PDC-3 and compare it with the E219K and Y221A variants. Titration curves generated from pH-replicated simulations were analyzed to extract K67 <italic>pK</italic><sub><italic>a</italic></sub> values. Our results indicate that, in wild-type PDC-3, K67 exhibits a <italic>pK</italic><sub><italic>a</italic></sub> in the range of approximately 8.50-8.79 (<xref rid="fig3" ref-type="fig">Figure 3C</xref> and <xref ref-type="fig" rid="fig3s2">figure Supplement 2</xref>). By contrast, the E219K mutation dramatically reduces the <italic>pK</italic><sub><italic>a</italic></sub> of K67 to approximately 6.32-6.71, causing K67 to be predominantly deprotonated (neutral) at physiological pH. This deprotonated form is conducive to K67 functioning as a ‘general base’ readily accepting a proton and thereby facilitating the nucleophilic attack of the S64 hydroxyl group on the β-lactam ring (<xref ref-type="bibr" rid="c64">Tripathi and Nair,2013</xref>, <xref ref-type="bibr" rid="c65">2016</xref>). The Y221A mutation also shifts <italic>pK</italic><sub><italic>a</italic></sub> of K67 down (7.60-8.06), though to a lesser degree than E219K, consistent with the hydrogen-bond occupancies observed in our simulations. As previously noted, the E219K and Y221A mutations weakens the tridentate hydrogen-bond networks (K67(NZ)-S64(OG), K67(NZ)-N152(OD1), K67(NZ)-G220(O)), thereby enabling K67 to more flexibly adjust both its conformation and its protonation state-a change that promotes effcient proton transfer (<xref rid="tbl1" ref-type="table">Table 1</xref>). Experimentally, these mutations also confer increased sensitivity to cephalosporin antibiotics, which aligns with the conformational and protonation-state shifts observed in the simulations (<xref ref-type="bibr" rid="c3">Barnes et al., 2018</xref>). Collectively, these findings reveal that the E219K and Y221A substitutions disrupt the tridentate hydrogen-bond network, which lowers the <italic>pK</italic><sub><italic>a</italic></sub> of K67 and enhances its ability to act as a general base. This elevated proton-transfer effciency, in turn, improves the enzyme’s catalytic performance.</p>
</sec>
<sec id="s2c">
<title>Substitutions enlarge the active-site pocket to accommodate bulkier R1 and R2 groups of β-lactams</title>
<p>From <xref rid="tbl1" ref-type="table">Table 1</xref>, we can observe that the wild-type PDC-3 forms a hydrogen bond K67(NZ)-G220(O) in 63.20% of simulations. However, in the variants G214R, E219K, E219G, and Y221A, the percentages of forming this hydrogen bond are greatly decreased, with fractions of formation ranging from 24.11% in G214R to 31.70% in E219G (<xref rid="fig4" ref-type="fig">Figure 4A, B</xref> and <xref ref-type="fig" rid="fig4s1">figure Supplement 1</xref>). In the Y150(N)-A292(O) interaction, the wild-type PDC-3 forms this hydrogen bond in 72.94% of simulations. The V211A, V211G, E219A, E219G, E219K, Y221A, and Y221H variants have significantly lower percentages of formation, ranging from 15.67% to 29.36%. Therefore, substitution of the V211, E219, and Y221 residues will affect this hydrogen bond considerably. In addition, approximately 55.09% of the structures form the hydrogen bond N287(ND2)-N314(OD1) in wild-type PDC-3. However, in the variant structures, most do not form this hydrogen bond, only a few do with a range of 18.72% to 36.42%. Residues G220 is positioned in the Ω-loop, while A292, N287, and N314 are located in the R2-loop. Therefore, the disruption of the K67(NZ)-G220(O) interaction in PDC-3 may lead to the expansion of the R1 site, allowing for substrates with larger R1 side chains such as ceftolozane and ceftazidime to be accommodated. Similarly, the loss of the Y150(N)-A292(O) and N287(ND2)-N314(OD1) interactions could potentially enlarge the R2 site of PDC-3, providing additional space for R2 side chains of cephalosporins.</p>
<fig id="fig4" position="float" fig-type="figure">
<label>Figure 4.</label>
<caption><title>Structural visualization of the enlarged active-site pockets.</title>
<p>(A) The K67(NZ)-G220(O), Y150(N)-A292(O), and N287(ND2)-N314(OD1) interactions in structures from wild-type PDC-3 (orange), V211A (green), and Y221A (blue) variants. The yellow dashed lines represent the interactions. (B) The active site pockets of wild-type PDC-3 (orange), V211A (green), and Y221A (blue) variants are shown as surface representation. <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>. The distance distributions of the three key hydrogen-bonding interactions (K67(NZ)-G220(O), Y150(N)-A292(O), and N287(ND2)-N314(OD1)). Each violin represents the probability density of observed distances, with median and quartiles indicated by the white dot and the thick black line inside the violin plot, respectively. <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>. The distribution of pocket volume and solvent accessible surface area for the wild-type PDC3 enzyme and nine mutants. Each violin represents the probability density of observed distances, with median and quartiles indicated by the white dot and the thick black line inside the violin plot, respectively. <xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3</xref>. Docking of ceftolozane into the active-site pockets of the wild-type PDC-3, V211A and Y221A variants.</p></caption>
<graphic xlink:href="578824v4_fig4.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<p>The confirmation of these observations can be supported by analyzing the pocket volumes and solvent accessible surface areas (<xref rid="tbl2" ref-type="table">Table 2</xref> and <xref rid="fig4s2" ref-type="fig">Figure 4 figure Supplement 2</xref>). In the simulations with the Y221A, E219K, and E219G variants, it was found that all three interactions were disrupted in the majority of structures. On the other hand, the G214A variant displayed relatively lower fractions of all three interactions compared to other variants. Consequently, nearly all variants exhibit significantly larger active-site volumes than the wild-type (WT) (all <italic>p</italic> &lt; 0.0001). The most pronounced expansions occur in Y221A (1381 ± 302 Å<sup>3</sup>), E219K (1279 ± 293 Å<sup>3</sup>), and E219G (1212 ± 250 Å<sup>3</sup>). By contrast, G214A (1075 ± 260 Å<sup>3</sup>; <italic>p</italic> = 0.0373) only slightly exceeds WT (1072 ± 158 Å<sup>3</sup>). The solvent-accessible surface area (SASA) shows a similar pattern, with each variant differing significantly from WT (<italic>p</italic> &lt; 0.0001). Notably, Y221A (157 ± 3 Å<sup>2</sup>) and G214R (157 ± 3 Å<sup>2</sup>) exhibit some of the largest increases in SASA, further suggesting an expanded active-site region that may accommodate bulkier R1 and R2 side chains in β-lactam substrates. As a result, we infer that the R1 site of the G214R, E219G, E219K, and Y221A variants should undergo a noticeable increase in size. Additionally, the R2 site is expected to experience an increase volume in all variants except G214A and G214R.</p>
<table-wrap id="tbl2" orientation="portrait" position="float">
<label>Table 2.</label>
<caption><title>Mean (± Standard Deviation) pocket volume (Å<sup>3</sup>) and solvent accessible surface area (Å<sup>2</sup>) in the active-site pocket for wild-type (WT) and its variants.</title>
<p>T-statistics and p-values were derived from two-sample t-tests comparing each mutant with WT. p-values below 0.0001 are reported as ‘p &lt; 0.0001’.</p></caption>
<graphic xlink:href="578824v4_tbl2.tif" mime-subtype="tiff" mimetype="image"/>
</table-wrap>
<p>A previous study by Barnes et al., has shown that G214R, E219G, E219K, and Y221A variants exhibit greater resistance to ceftolozane and ceftazidime (<xref ref-type="bibr" rid="c3">Barnes et al., 2018</xref>). In contrast, their resistance to cefotaxime and cefepime, which have smaller R1 side chains, was not significantly affected (<xref ref-type="bibr" rid="c3">Barnes et al., 2018</xref>). Additionally, metadynamics studies have also indicated that there will be a lower free energy barrier for the acylation reaction when this interaction between A220 (the equivalent position of G220 in PDC-3) and K67 is broken in the complex of CBL and aztreonam (<xref ref-type="bibr" rid="c64">Tripathi and Nair, 2013</xref>). However, only E219G, E219K, and Y221A demonstrate an obvious increase in resistance to ceftolozane while other variants only show minor changes. This difference in resistance might be attributed to the relatively smaller R1 site. The other variants had more structures capable of forming interactions between K67(NZ) and G220(O), which could potentially reduce the impact on their resistance to ceftolozane.</p>
</sec>
<sec id="s2d">
<title>Markov State Modeling Characterizes Key Hydrogen Bond Transitions</title>
<p>The utilization of Markov state models (MSMs) enabled the analysis of long-term conformational alterations of wild-type PDC-3 and its variants by filtering out local fluctuations related to thermal motion and focusing on underlying conformational transformations (<xref ref-type="bibr" rid="c6">Bowman et al., 2009</xref>; <xref rid="c23" ref-type="bibr">Husic and Pande, 2018</xref>; <xref ref-type="bibr" rid="c56">Scherer et al., 2015</xref>; <xref ref-type="bibr" rid="c63">Trendelkamp-Schroer and Noe, 2013</xref>). Previous analyses demonstrated that, in addition to the catalytic site, the most significant structural changes occur in the Ω- and R2-loops; consequently, hydrogen bonds and salt bridges in those loops and in the catalytic site were identified for MSM construction. Distances for all relevant interactions were computed in (i) the active motifs (S<sup>64</sup>XXK<sup>67</sup>, Y<sup>150</sup>SN<sup>152</sup>, K<sup>315</sup>TG<sup>317</sup>), (ii) the Ω-loop (residues G183–S226), and (iii) the R2-loop (residues L280–Q310). To establish the correlation between structural dynamics and active-site pockets, correlation coeffcients were computed between the distances of these interactions and the volume of the active-site pocket. A correlation coeffcient exceeding 0.3 or falling below -0.3 indicates a positive or negative relationship, respectively. Only the distances of salt bridges and hydrogen bonds that exhibited a positive or negative relationship with the volume of the active site pockets were selected as features to construct the MSMs. This resulted in the selection of 8 salt bridges and 24 hydrogen bonds (<xref rid="tbl3" ref-type="table">Table 3</xref>).</p>
<table-wrap id="tbl3" orientation="portrait" position="float">
<label>Table 3.</label>
<caption><title>Correlation coeffcients between the distances of key interactions (32 features) and volume of active-site pocket.</title></caption>
<graphic xlink:href="578824v4_tbl3.tif" mime-subtype="tiff" mimetype="image"/>
</table-wrap>
<p>From the metastable state results, we observe that E219K adopts a highly stable conformation in which all the tridentate hydrogen-bonding interactions (K67(NZ)-S64(OG), K67(NZ)-N152(OD1) and K67(NZ)-G220(O) mentioned above are broken (<xref rid="fig5" ref-type="fig">Figure 5</xref>). Notably, this ‘fully broken’ configuration appears only in E219K and Y221A variants (states 1, 6, and 7 in E219K, and state 3 in Y221A). The mean first passage time (MFPT) data indicate that once the E219K variant forms one of these bonds-broken states, it remains there for thousands of nanoseconds (8,262.0 ± 2,573.0 ns to 12,769.0 ± 3,327.0 ns) before transitioning to a bonds-formed state (state 3). Likewise, the reverse process also occurs on a microsecond timescale, demonstrating that both directions are kinetically stabilized in E219K. As a result, E219K displays two distinct energy minima in its free-energy landscape, whereas other variants typically show only one (<xref rid="fig5" ref-type="fig">Figure 5A</xref>). Prolonged residence in a bonds-broken conformation implies that K67 is more likely to remain deprotonated (consistent with its reduced <italic>pK</italic><sub><italic>a</italic></sub> in constant-pH MD simulations), enhancing catalytic function. By contrast, in Y221A, the equivalent bonds-broken state (state 3) shifts more readily into other metastable states, including the most stable state 7 (bonds-formed), in only 780.2 ± 46.8 ns. Although the reverse transition from bonds-formed to bonds-broken in Y221A requires a somewhat longer 1,737.6 ± 139.7 ns, this timescale remains far shorter than E219K’s multi-microsecond range. Consequently, Y221A can dynamically switch between ‘formed’ and ‘broken’ conformations with much greater ease. This difference in conformational kinetics helps explain differences in how each mutant enhances hydrolysis rates—E219K achieve it through stable, long-lived ‘active’ conformations, while Y221A rely on faster switching and conformational plasticity.</p>
<fig id="fig5" position="float" fig-type="figure">
<label>Figure 5.</label>
<caption><title>Free energy landscapes and metastable-state distributions from Markov State Models reveal key conformational transitions in wild-type PDC-3 and its variants.</title>
<p>(A) The free energy landscape for the microstates of the wild-type PDC-3 and its mutants. (B) The metastable states grouped from microstates of PDC-3 and its variants systems. The microstates were grouped by the PCCA method into metastable states in all systems. <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>. The convergence behaviour of the implied timescales related to the first ten slowest processes. <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>. The Chapman Kolmogorov test plot of wild-type PDC-3. <xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3</xref>. The Chapman Kolmogorov test plot of V211A variant. <xref ref-type="fig" rid="fig5s4">Figure 5—figure supplement 4</xref>. The Chapman Kolmogorov test plot of V211G variant. <xref ref-type="fig" rid="fig5s5">Figure 5—figure supplement 5</xref>. The Chapman Kolmogorov test plot of G214A variant. <xref ref-type="fig" rid="fig5s6">Figure 5—figure supplement 6</xref>. The Chapman Kolmogorov test plot of G214R variant. <xref ref-type="fig" rid="fig5s7">Figure 5—figure supplement 7</xref>. The Chapman Kolmogorov test plot of E219A variant. <xref ref-type="fig" rid="fig5s8">Figure 5—figure supplement 8</xref>. The Chapman Kolmogorov test plot of E219G variant. <xref ref-type="fig" rid="fig5s9">Figure 5—figure supplement 9</xref>. The Chapman Kolmogorov test plot of E219K variant. <xref ref-type="fig" rid="fig5s10">Figure 5—figure supplement 10</xref>. The Chapman Kolmogorov test plot of Y221A variant. <xref ref-type="fig" rid="fig5s11">Figure 5—figure supplement 11</xref>. The Chapman Kolmogorov test plot of Y221H variant. <xref ref-type="fig" rid="fig5s12">Figure 5—figure supplement 12</xref>. TICA plot illustrates the distribution of wild-type PDC-3 and its variants with the colour indicating the K67(NZ)-S64(OG) distance. <xref ref-type="fig" rid="fig5s13">Figure 5—figure supplement 13</xref>. TICA plot illustrates the distribution of wild-type PDC-3 and its variants with the colour indicating the K67(NZ)-N152(OD1 distance. <xref ref-type="fig" rid="fig5s14">Figure 5—figure supplement 14</xref>. TICA plot illustrates the distribution of wild-type PDC-3 and its variants with the colour indicating the K67(NZ)-G220(O) distance. <xref ref-type="fig" rid="fig5s15">Figure 5—figure supplement 15</xref>. TICA plot illustrates the distribution of wild-type PDC-3 and its variants with the colour indicating the Y150(N)-A292(O) distance. <xref ref-type="fig" rid="fig5s16">Figure 5—figure supplement 16</xref>. TICA plot illustrates the distribution of wild-type PDC-3 and its variants with the colour indicating the N287(ND2)-N314(OD1) distance.</p></caption>
<graphic xlink:href="578824v4_fig5.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<p>The hydrogen bond between Y150(N)-A292(O) is commonly broken in variants, but certain metastable states exist where it re-forms, e.g., V211A (state 7), G214A (states 5, 7, 8), G214R (state 7), and E219K (state 6). This hydrogen bond is likely to play a crucial role in maintaining the R2-loop’s proximity to the active site and stabilizing other hydrogen bonds. Although the fraction of time that Y150(N)–A292(O) is formed in V211A is comparable to other variants, the R2-loop in this mutant is more flexible because the bond can form and break with relative ease (<xref rid="tbl1" ref-type="table">Table 1</xref>). Specifically, transitioning in V211A from a bonds-broken state (state 6) to a bonds-formed state (state 7) takes 876.8 ± 78.0 ns, whereas the reverse transition requires 1,874.8 ± 177.6 ns. These timescales show that V211A’s R2-loop toggles between ‘broken’ and ‘formed’ states on the order of nanoseconds to low microseconds, signifying its flexibility. By contrast, G214A exhibits an asymmetry in its transitions: moving from bonds-broken (state 3) to bonds-formed (states 5, 7, 8) takes 1,608.2–2,089.0 ns, but returning to bonds-broken requires 13,175.0–13,657.1 ns. This disparity implies that once the bond is formed, G214A’s loop conformation becomes kinetically stabilized in a ‘closed’ state. G214R shows a similar pattern, requiring 1,701.6 ± 551.9 ns to transition from bonds-broken state (state 4) to bonds-formed state (state 7), but 24,040.6 ± 7,186.8 ns to revert, again indicating that forming the hydrogen bond is far easier than breaking it. Meanwhile, E219K encounters high energy barriers in both directions, based on its long mean first passage times (MFPT), suggesting stable conformations whether the bond is formed or broken.</p>
<p>We also observe that V211A, V211G, G214R, E219G, and E219K variants show metastable states with N287(ND2)-N314(OD1) completely broken. In the case of V211A, state 7 is dominated by conformations that have formed these hydrogen bonds. However, state 3 and state 4 show that the hydrogen bonds are lost. The transition from bonds-formed states (state 2) to bonds-broken states (state 3) is facile and takes only 133.3 ± 12.8 ns, while the transition from bonds-broken states (state 3) to bonds-formed states (state 5) takes 238.4 ± 27.2 ns. In V211G, state 3 and state 4 states exhibit the loss of these hydrogen bonds. The formation of them takes only 48.3 ± 4.1 ns, whereas breaking them takes 613.7 ± 56.6 ns. Despite the Ω-loop being highly stable in V211A and V211G, these states can easily adopt different conformations for the R2-loop, thereby accommodating β-lactams with larger R2 sites. In E219G, state 6 and state 7 show these hydrogen bonds formed and broken, respectively. The MFPT from bonds-formed states (state 6) to bonds-broken states (state 7) is 220.9 ± 23.5 ns, while the MFPT from bonds-broken states (state 7) to bonds-formed states (state 6) is 333.1 ± 19.7 ns. Therefore, high flexibility also can be observed in the R2-loop of the E219G variant. In the case of G214R, the transformation from bonds-broken states (state 3 and 4) to bonds-formed states (state 6), which corresponds to the formation of the hydrogen bond, takes 411.3 ± 21.5 ns and 53.8 ± 5.8 ns, respectively. Conversely, the transition from bonds-formed states (state 6) to bonds-broken states (state 3 and 4) takes much longer, requiring 1393.1 ± 108.4 ns and 1557.8 ± 223.1 ns, respectively. This imbalance means G214R can ‘lock in’ the formed conformation but can still reorganize if given enough time. In the E219K variant, the hydrogen bond is broken in state 1 and state 5, and the transition to state 6, where the hydrogen bond is formed, takes 1621.4 ± 415.5 ns and 4360.4 ± 972.0 ns, respectively. Conversely, the transition from bonds-formed states (state 6) to bonds-broken states (state 1 and state5) takes 3408.7 ± 724.0 ns and 11162.4 ± 3016.3 ns. Therefore, V211A, V211G, and E219G can rapidly form or disrupt the N287(ND2)–N314(OD1) hydrogen bond, whereas G214R and E219K exhibit more substantial kinetic barriers to these transitions.</p>
</sec>
</sec>
<sec id="s3">
<title>Conclusions</title>
<p>This investigation of the effects of substitutions in the PDC-3 β-lactamase has provided valuable information on the protein’s dynamics. The study indicates that substitutions can have a significant impact on the stability and flexibility of the Ω-loop and R2-loop, both of which are critical for proper β-lactamase function. Specifically, the G214A, G214R, E214G, and Y221A variants, as well as the wild-type PDC-3, exhibit high flexibility in the Ω-loop, while the V211A and E219G variants show the highest flexibility in the R2-loop. Moreover, a three-pronged hydrogen-bond network around K67—specifically K67(NZ)–S64(OG), K67(NZ)–N152(OD1), and K67(NZ)–G220(O)—governs the proton-transfer step essential for β-lactam hydrolysis. When these three bonds remain intact, K67 tends to stay protonated, limiting its availability to accept protons from S64. Mutations such as E219K and Y221A disrupt this tridentate network, reducing K67’s <italic>pK</italic><sub><italic>a</italic></sub> and facilitating effcient proton transfer in hydrolysis. Additionally, K67(NZ)–G220(O), the Y150(N)–A292(O) and N287(ND2)–N314(OD1) interactions further modulate R1/R2-loop conformations. Breaking these hydrogen bonds typically shifts the active site to an ‘open’ configuration, accommodating larger cephalosporin substrates. Conversely, their re-formation favors a ‘closed’ state that may stabilize smaller or structurally simpler β-lactams. Overall, the findings of this study provide significant insight into the dynamics of the PDC-3 β-lactamase, revealing the critical roles played by the Ω-loop and R2-loop in its function. These insights gained from this study will aid in the design of more potent antibiotics and β inhibitors for treating bacterial infections.</p>
</sec>
<sec id="s4">
<title>Methods</title>
<sec id="s4a">
<title>Initial structure preparation</title>
<p>All-atom MD simulations of wild-type PDC-3 and its variants were performed. First, the simulations of their conformations were initiated from the X-ray crystallographic structure (PDB ID: 4HEF) at 1.86 Å, after modification of T79A (<xref ref-type="bibr" rid="c28">Lahiri et al., 2013</xref>). PDC-3 wild-type and nine variants (V211A, V211G, G214A, G214R, E219A, E219G, E219K, Y221A, and Y221H) were constructed <italic>in silico</italic> using the ICM mutagenesis program (<xref ref-type="bibr" rid="c1">Abagyan et al., 1994</xref>). To ensure the accurate protonation states of the protein, PROPKA 3.0 was employed to assign the protonation states of N-terminus, C-terminus, cationic residues, and anionic residues based on a neutral pH local environment and the protonation states and side chain orientations were also checked by visual inspection (<xref ref-type="bibr" rid="c41">Olsson et al., 2011</xref>). In addition, all acidic residues were negatively charged, while alkaline Lys and Arg residues remained positively charged. His was protonated based upon the suggestion by PROPKA 3.0 analysis and also checked by visual inspection.</p>
</sec>
<sec id="s4b">
<title>AdaptiveBandit simulations</title>
<p>Adaptive Bandit MD (AB-MD) simulation is a reinforcement learning based enhanced sampling method that offers a more effcient exploration of the protein’s conformational space while maintaining unbiased, thermodynamically accurate ensembles (<xref ref-type="bibr" rid="c45">Pérez et al., 2020</xref>). The advantage of using AB-MD is that it does not alter the underlying potential energy surface, it retains physically realistic dynamics and eliminates the need for reweighting of biased trajectories. As a result, AB-MD can attain a similar or greater depth of conformational sampling with significantly less total simulation time (i.e. lower computational cost) than either extended conventional MD or other enhanced sampling approaches.</p>
<p>The WT and variant structures served as the starting point for a later molecular dynamics (MD) simulation. Multi-microsecond MD simulations of wild-type PDC-3 and its variants were conducted using the Amberff14SB force-field (<xref ref-type="bibr" rid="c32">Maier et al., 2015</xref>). All simulations were run using the ACEMD engine (<xref ref-type="bibr" rid="c16">Doerr et al., 2016</xref>; <xref ref-type="bibr" rid="c20">Harvey et al., 2009</xref>). Each structure was solvated in a pre-equilibrated periodic cubic box of water molecules represented by the three-point charge TIP3P model, whose boundary is at least 10 Å from any atoms so that the protein does not interact with its periodic images. Periodic boundary conditions in all directions were utilized to reduce finite system size effects. The potassium ions were added to make each system electrically neutral. Long-range electrostatic interactions were computed using the particle mesh Ewald summation method (<xref ref-type="bibr" rid="c9">Cerutti et al., 2009</xref>). Subsequently, each system was energy minimized for 5000 steps by conjugate gradient to remove any local atomic clashes and then equilibrated for 5 ns at 1 atmospheric pressure using Berendsen barostat (<xref ref-type="bibr" rid="c17">Feenstra et al., 1999</xref>).</p>
<p>Initial velocities within each simulation were sampled from Boltzmann distribution at temperature of 300 K. Isothermic-isobaric NVT ensemble using a Langevin thermostat with a damping of 0.1 ps-1 and hydrogen mass repartitioning scheme to achieve time steps of 4 fs. Multiple short MSM-based adaptively sampled simulations were run using the ACEMD molecular dynamics engine (<xref ref-type="bibr" rid="c16">Doerr et al., 2016</xref>; <xref ref-type="bibr" rid="c20">Harvey et al., 2009</xref>). The standard adaptive sampling algorithm performs several rounds of short parallel simulations. To avoid any redundant sampling, the algorithm generates an Markov state model (MSM) and uses the stationary distribution of each state to obtain an estimate of their free energy. It then selects any sampled conformation from a low free energy stable state and respawns a new round of simulations. In this context, the MetricSelfDistance function was set to consider the number of native Cα contacts formed for all residues, which were then used to build the MSMs. The exploration value was 0.01 and goal-scoring function was set to 0.3. For each round, 4 simulations of 300 ns were run in parallel until the cumulative time exceeded 30 µs. The trajectory frames were saved every 0.1 ns. 100 trajectories for each system were collected with each trajectory counting 3000 frames.</p>
</sec>
<sec id="s4c">
<title>Constant pH molecular dynamics</title>
<p>To investigate the protonation behavior of K67 in wild-type PDC-3 and its E219K and Y221A variants, K67, Y150, E/K219, and K315 were selected as titratable sites in CpHMD simulations because they lie in proximity to the site of interest (K67) and together form its immediate electrostatic network (<xref ref-type="bibr" rid="c27">Kim et al., 2015</xref>; <xref ref-type="bibr" rid="c28">Lahiri et al., 2013</xref>). The starting structures were identical to those used for AB-MD. The simulations performed in the Amber suite with the ff99SB force field and an implicit Generalized Born (GB) solvent model (<xref ref-type="bibr" rid="c32">Maier et al., 2015</xref>; <xref ref-type="bibr" rid="c37">Mongan et al., 2004</xref>). The protein–solvent complex was energy-minimized for a total of 5,000 steps—10 steps of steepest-descent followed by 4,990 steps of conjugate-gradient—with harmonic positional restraints (10 kcal/mol·Å<sup>2</sup>) on the backbone atoms to relax side-chain clashes (<xref ref-type="bibr" rid="c7">Brooks et al., 1983</xref>; <xref ref-type="bibr" rid="c57">Schlegel, 1982</xref>). The system was then heated from 10 K to 300 K over 1 ns, followed by another 1 ns of equilibration at 300 K under Langevin dynamics (<xref ref-type="bibr" rid="c58">Schneider and Stoll, 1978</xref>), with a 2 fs time step and SHAKE constraints on hydrogen-containing bonds. During heating, a weaker restraint (2 kcal/mol·Å<sup>2</sup>) was applied to the backbone atoms to maintain the overall fold while allowing side-chain relaxation, and protonation states were kept fixed in this phase. Equilibrium simulations under constant pH conditions were subsequently conducted at pH 5, 6, 7, 8, 9, 10, and 11 by periodically (every 10 steps) attempting protonation-state changes via a Monte Carlo protocol (<xref ref-type="bibr" rid="c27">Kim et al., 2015</xref>). Each pH condition consisted of 50 ns of equilibration followed by 200 ns of production. To confirm convergence, the deprotonation fraction of each residue was monitored over time and found to reach a stable plateau within the final portion of the production simulations. Consequently, the last 50 ns of production for each pH value were used to calculate the deprotonation fractions, ensuring that the analyzed region reflected a converged state. Each system was simulated in triplicate, ultimately providing consistent K67 <italic>pK</italic><sub><italic>a</italic></sub> estimates for the wild-type, E219K, and Y221A variants. All analyses were done with AmberTools <italic>cphstats</italic> and in-house Python scripts (<xref ref-type="bibr" rid="c8">Case et al., 2023</xref>).</p>
</sec>
<sec id="s4d">
<title>Markov state models</title>
<p>The PyEMMA software (version 2.5.9) was employed to construct the Markov state models (<xref rid="c23" ref-type="bibr">Husic and Pande, 2018</xref>; <xref ref-type="bibr" rid="c56">Scherer et al., 2015</xref>). The software determines the kinetically relevant metastable states and their inter-conversion rate from all trajectories of the all-atom molecular dynamics of the wild-type PDC-3 and its variants. Firstly, to evaluate the MSM construction, the conformations defining each frame of the MD trajectories were converted into an intuitive basis. In this step, the features which can represent the slow dynamical modes of these systems were selected. Then, the conformational space was projected to a two-dimensional space using time-lagged independent component analysis (TICA) (<xref ref-type="bibr" rid="c46">Perez-Heandez and Noe, 2016</xref>). Using the <italic>k</italic>-means clustering technique, all conformations from MD simulations were grouped into microstates based on the TICA embedding (<xref ref-type="bibr" rid="c44">Peng et al., 2018</xref>). The conformations in the same cluster are geometrically similar and interconvert quickly. After that, the transition matrix between the microstates was built using Bayesian estimation at the appropriate lag time (<xref ref-type="bibr" rid="c63">Trendelkamp-Schroer and Noe, 2013</xref>). The lag time was selected where the implied time scales converged, and the transitions between the microstates became the Markovian process. Each indicated time scale represents the average transition time between two groups of states. The microstates were then clustered into a few metastable states using Perron cluster cluster analysis (PCCA) based on their kinetic similarities (<xref ref-type="bibr" rid="c6">Bowman et al., 2009</xref>). Additionally, the Chapman-Kolmogorov (CK) test was performed to validate the constructed model further (<xref ref-type="bibr" rid="c2">Barendregt et al., 2019</xref>). The CK test measures the reliability of the Markov state models by comparing the predicted residence probability of each microstate obtained from MSMs with those directly computed from MD simulations at longer timescales. Furthermore, the free energies for each metastable state (<italic>S</italic><sub><italic>i</italic></sub>) were computed from its stationary MSM probability π using the relation:
<disp-formula id="eqn1">
<graphic xlink:href="578824v4_eqn1.gif" mime-subtype="gif" mimetype="image"/>
</disp-formula>
where <italic>π</italic><sub><italic>i</italic></sub> denotes the MSM stationary weight of the <italic>j</italic>th metastable state, <italic>k</italic><sub><italic>B</italic></sub> is the Boltzmann constant, and <italic>T</italic> is the temperature. Subsequently, the mean first passage times (MFPT) out of and into the macrostate Si were computed using the Bayesian MSM (<xref ref-type="bibr" rid="c49">Polizzi et al., 2016</xref>).</p>
</sec>
<sec id="s4e">
<title>Structural analysis</title>
<p>MDTraj is a robust software package that facilitates the analysis of molecular dynamics (MD) simulations by enabling the manipulation of MD trajectory data from a variety of files (<xref ref-type="bibr" rid="c35">McGibbon et al., 2015</xref>). The package provides Python-based tools that allow for the effcient computation of structural and dynamic properties of biomolecules. In this study, MDTraj was utilized to compute several important metrics that are critical in the analysis of MD simulations. Specifically, we used MDTraj to calculate the root-mean-square-fluctuations (RMSF) and root-mean-square-deviation (RMSD) of the protein structure, as well as the x1 torsion angle, hydrogen bonds, salt bridges and the solvent-accessible surface area (SASA). RMSF quantifies the average positional fluctuation of the Cα atom of each residue during the MD simulation relative to its position in the equilibrated reference structures. RMSD quantifies the average displacement of the protein’s Cα atoms from their positions in an equilibrated reference structure over time. In addition, MDLovoFit was used to show the graphical representation of RMSD results (<xref ref-type="bibr" rid="c34">Martinez, 2015</xref>). Furthermore, pairwise RMSD analyses were performed using the pytraj package, which allowed us to assess the structural similarities and differences among the conformations sampled during the simulation (<xref ref-type="bibr" rid="c54">Roe and Cheatham, 2013</xref>). The x1 torsion angles were calculated for each residue except for alanine and glycine. Hydrogen bonds were defined as a distance of less than 3.5 Å between a hydrogen bond donor and acceptor, with a hydrogen-donor-acceptor angle greater than 30°. Salt bridges were defined as a distance of less than 4.0 Å between a positively charged amino acid side chain (lysine or arginine) and a negatively charged side chain (aspartate or glutamate). The volume of the active site pocket was calculated using ParkVFinder (<xref ref-type="bibr" rid="c19">Guerra et al., 2020</xref>). The two-sample t-tests were performed for the SASA and volume. Visualization of the structures of protein was performed using PyMOL (<xref ref-type="bibr" rid="c59">Schrödinger and DeLano, 2020</xref>).</p>
</sec>
</sec>
</body>
<back>
<sec id="das" sec-type="data-availability">
<title>Data availability</title>
<p>All files required to run the simulations (topology, coordinates, input), processed trajectories (xtc), corresponding coordinates (pdb), metastable PDB files for each system described in this manuscript can be downloaded from the DOI <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.57760/sciencedb.15876">https://doi.org/10.57760/sciencedb.15876</ext-link></p>
</sec>
<sec sec-type="supplementary" id="supplementary19">
<title>Figure supplements</title>
<fig id="fig2s1" position="float" fig-type="figure">
<label>Figure 2—figure supplement 1.</label>
<caption><title>The distribution of RMSD values of the wild-type PDC-3 and its variants.</title>
<p>The three violin plots illustrate the RMSD values of the complete protein, the Ω-loop, and the R2-loop, respectively. The width of each violin plot represents the density of data points at a given RMSD value. The median and quartiles are indicated by the white dot and the thick black line inside the violin plot, respectively. The crystal structure PDB ID 4HEF is used as the reference.</p></caption>
<graphic xlink:href="578824v4_fig2_S1.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<fig id="fig2s2" position="float" fig-type="figure">
<label>Figure 2—figure supplement 2.</label>
<caption><title>RMSD as a function of the fraction of the atoms considered in the alignment.</title></caption>
<graphic xlink:href="578824v4_fig2_S2.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<fig id="fig3s1" position="float" fig-type="figure">
<label>Figure 3—figure supplement 1.</label>
<caption><title>The distance distributions of the tridentate hydrogen-bonding interactions (K67(NZ)-S64(OG), K67(NZ)-N152(OD1) and K67(NZ)-G220(O).</title>
<p>Each violin represents the probability density of observed distances, with median and quartiles indicated by the white dot and the thick black line inside the violin plot, respectively.</p></caption>
<graphic xlink:href="578824v4_fig3_S1.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<fig id="fig3s2" position="float" fig-type="figure">
<label>Figure 3—figure supplement 2.</label>
<caption><title>Time-resolved deprotonation of K67 in WT, E219K, and Y221A over 200-ns constant-pH MD simulations at six pH values (5, 6, 7, 8, 9, 10, and 11).</title>
<p>Each panel plots the deprotonated fraction of K67 versus simulation time for one replica.</p></caption>
<graphic xlink:href="578824v4_fig3_S2.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<fig id="fig4s1" position="float" fig-type="figure">
<label>Figure 4—figure supplement 1.</label>
<caption><title>The distance distributions of the three key hydrogen-bonding interactions (K67(NZ)-G220(O), Y150(N)-A292(O), and N287(ND2)-N314(OD1)).</title>
<p>Each violin represents the probability density of observed distances, with median and quartiles indicated by the white dot and the thick black line inside the violin plot, respectively.</p></caption>
<graphic xlink:href="578824v4_fig4_S1.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<fig id="fig4s2" position="float" fig-type="figure">
<label>Figure 4—figure supplement 2.</label>
<caption><title>The distribution of pocket volume and solvent accessible surface area for the wild-type PDC3 enzyme and nine mutants.</title>
<p>Each violin represents the probability density of observed distances, with median and quartiles indicated by the white dot and the thick black line inside the violin plot, respectively.</p></caption>
<graphic xlink:href="578824v4_fig4_S2.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<fig id="fig4s3" position="float" fig-type="figure">
<label>Figure 4—figure supplement 3.</label>
<caption><title>Docking of ceftolozane into the active-site pockets of the wild-type PDC-3, V211A and Y221A variants.</title></caption>
<graphic xlink:href="578824v4_fig4_S3.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<fig id="fig5s1" position="float" fig-type="figure">
<label>Figure 5—figure supplement 1.</label>
<caption><title>The convergence behaviour of the implied timescales related to the first ten slowest processes.</title></caption>
<graphic xlink:href="578824v4_fig5_S1.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<fig id="fig5s2" position="float" fig-type="figure">
<label>Figure 5—figure supplement 2.</label>
<caption><title>The Chapman Kolmogorov test plot of wild-type PDC-3.</title></caption>
<graphic xlink:href="578824v4_fig5_S2.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<fig id="fig5s3" position="float" fig-type="figure">
<label>Figure 5—figure supplement 3.</label>
<caption><title>The Chapman Kolmogorov test plot of V211A variant.</title></caption>
<graphic xlink:href="578824v4_fig5_S3.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<fig id="fig5s4" position="float" fig-type="figure">
<label>Figure 5—figure supplement 4.</label>
<caption><title>The Chapman Kolmogorov test plot of V211G variant.</title></caption>
<graphic xlink:href="578824v4_fig5_S4.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<fig id="fig5s5" position="float" fig-type="figure">
<label>Figure 5—figure supplement 5.</label>
<caption><title>The Chapman Kolmogorov test plot of G214A variant.</title></caption>
<graphic xlink:href="578824v4_fig5_S5.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<fig id="fig5s6" position="float" fig-type="figure">
<label>Figure 5—figure supplement 6.</label>
<caption><title>The Chapman Kolmogorov test plot of G214R variant.</title></caption>
<graphic xlink:href="578824v4_fig5_S6.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<fig id="fig5s7" position="float" fig-type="figure">
<label>Figure 5—figure supplement 7.</label>
<caption><title>The Chapman Kolmogorov test plot of E219A variant.</title></caption>
<graphic xlink:href="578824v4_fig5_S7.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<fig id="fig5s8" position="float" fig-type="figure">
<label>Figure 5—figure supplement 8.</label>
<caption><title>The Chapman Kolmogorov test plot of E219G variant.</title></caption>
<graphic xlink:href="578824v4_fig5_S8.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<fig id="fig5s9" position="float" fig-type="figure">
<label>Figure 5—figure supplement 9.</label>
<caption><title>The Chapman Kolmogorov test plot of E219K variant.</title></caption>
<graphic xlink:href="578824v4_fig5_S9.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<fig id="fig5s10" position="float" fig-type="figure">
<label>Figure 5—figure supplement 10.</label>
<caption><title>The Chapman Kolmogorov test plot of Y221A variant.</title></caption>
<graphic xlink:href="578824v4_fig5_S10.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<fig id="fig5s11" position="float" fig-type="figure">
<label>Figure 5—figure supplement 11.</label>
<caption><title>The Chapman Kolmogorov test plot of Y221H variant.</title></caption>
<graphic xlink:href="578824v4_fig5_S11.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<fig id="fig5s12" position="float" fig-type="figure">
<label>Figure 5—figure supplement 12.</label>
<caption><title>TICA plot illustrates the distribution of wild-type PDC-3 and its variants with the colour indicating the K67(NZ)-S64(OG) distance.</title></caption>
<graphic xlink:href="578824v4_fig5_S12.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<fig id="fig5s13" position="float" fig-type="figure">
<label>Figure 5—figure supplement 13.</label>
<caption><title>TICA plot illustrates the distribution of wild-type PDC-3 and its variants with the colour indicating the K67(NZ)-N152(OD1 distance.</title></caption>
<graphic xlink:href="578824v4_fig5_S13.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<fig id="fig5s14" position="float" fig-type="figure">
<label>Figure 5—figure supplement 14.</label>
<caption><title>TICA plot illustrates the distribution of wild-type PDC-3 and its variants with the colour indicating the K67(NZ)-G220(O) distance.</title></caption>
<graphic xlink:href="578824v4_fig5_S14.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<fig id="fig5s15" position="float" fig-type="figure">
<label>Figure 5—figure supplement 15.</label>
<caption><title>TICA plot illustrates the distribution of wild-type PDC-3 and its variants with the colour indicating the Y150(N)-A292(O) distance.</title></caption>
<graphic xlink:href="578824v4_fig5_S15.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<fig id="fig5s16" position="float" fig-type="figure">
<label>Figure 5—figure supplement 16.</label>
<caption><title>TICA plot illustrates the distribution of wild-type PDC-3 and its variants with the colour indicating the N287(ND2)-N314(OD1) distance.</title></caption>
<graphic xlink:href="578824v4_fig5_S16.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
</sec>
<ack>
<title>Acknowledgements</title>
<p>Research reported herein was supported in part by funds the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number R01AI063517 to RAB and SH. The content is solely the responsibility of the authors and does not necessarily represent the offcial views of the Department of Veterans Affairs or the National Institutes of Health.</p>
</ack>
<sec id="additional-files" sec-type="supplementary-material">
<title>Additional files</title>
<supplementary-material id="supp1">
<label>Figure 5 source data 1.</label>
<caption>
<title>The mean first passage time (MFPT) estimates.</title>
</caption>
<media xlink:href="supplements/578824_file03.docx"/>
</supplementary-material>
</sec>
<ref-list>
<title>References</title>
<ref id="c1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Abagyan</surname> <given-names>R</given-names></string-name>, <string-name><surname>Totrov</surname> <given-names>M</given-names></string-name>, <string-name><surname>Kuznetsov</surname> <given-names>D.</given-names></string-name></person-group> <article-title>ICM—A new method for protein modeling and design: Applications to docking and structure prediction from the distorted native conformation</article-title>. <source>journal of Computational Chemistry</source>. <year>1994</year>; <volume>15</volume>(<issue>5</issue>):<fpage>488</fpage>–<lpage>506</lpage>. <ext-link ext-link-type="uri" xlink:href="https://onlinelibrary.wiley.com/doi/10.1002/jcc.540150503">https://onlinelibrary.wiley.com/doi/10.1002/jcc.540150503</ext-link>, doi: <pub-id pub-id-type="doi">10.1002/jcc.540150503</pub-id>.</mixed-citation></ref>
<ref id="c2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Barendregt</surname> <given-names>NW</given-names></string-name>, <string-name><surname>Josic</surname> <given-names>K</given-names></string-name>, <string-name><surname>Kilpatrick</surname> <given-names>ZP</given-names></string-name></person-group>. <article-title>Analyzing dynamic decision-making models using Chapman-Kolmogorov equations</article-title>. <source>J Comput Neurosci</source>. <year>2019</year> <month>Dec</month>; <volume>47</volume>(<issue>2–3</issue>):<fpage>205</fpage>–<lpage>222</lpage>. <pub-id pub-id-type="pmid">31734803</pub-id>, doi: <pub-id pub-id-type="doi">10.1007/s10827-019-00733-5</pub-id>.</mixed-citation></ref>
<ref id="c3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Barnes</surname> <given-names>MD</given-names></string-name>, <string-name><surname>Taracila</surname> <given-names>MA</given-names></string-name>, <string-name><surname>Rutter</surname> <given-names>JD</given-names></string-name>, <string-name><surname>Bethel</surname> <given-names>CR</given-names></string-name>, <string-name><surname>Galdadas</surname> <given-names>I</given-names></string-name>, <string-name><surname>Hujer</surname> <given-names>AM</given-names></string-name>, <string-name><surname>Caselli</surname> <given-names>E</given-names></string-name>, <string-name><surname>Prati</surname> <given-names>F</given-names></string-name>, <string-name><surname>Dekker</surname> <given-names>JP</given-names></string-name>, <string-name><surname>Papp-Wallace</surname> <given-names>KM</given-names></string-name>, <string-name><surname>Haider</surname> <given-names>S</given-names></string-name>, <string-name><surname>Bonomo</surname> <given-names>RA</given-names></string-name></person-group>. <article-title>Deciphering the Evolution of Cephalosporin Resistance to Ceftolozane-Tazobactam in Pseudomonas aeruginosa</article-title>. <source>mBio</source>. <year>2018</year>; <volume>9</volume>(<issue>6</issue>). <pub-id pub-id-type="pmid">30538183</pub-id>, doi: <pub-id pub-id-type="doi">10.1128/mBio.02085-18</pub-id>.</mixed-citation></ref>
<ref id="c4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bhattarai</surname> <given-names>A</given-names></string-name>, <string-name><surname>Miao</surname> <given-names>Y.</given-names></string-name></person-group> <article-title>Gaussian accelerated molecular dynamics for elucidation of drug pathways</article-title>. <source>Expert Opin Drug Discov</source>. <year>2018</year> <month>Nov</month>; <volume>13</volume>(<issue>11</issue>):<fpage>1055</fpage>–<lpage>1065</lpage>. <pub-id pub-id-type="pmid">30371112</pub-id>, doi: <pub-id pub-id-type="doi">10.1080/17460441.2018.1538207</pub-id>.</mixed-citation></ref>
<ref id="c5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Boot</surname> <given-names>A</given-names></string-name>, <string-name><surname>Etchebest</surname> <given-names>C</given-names></string-name>, <string-name><surname>de Breve</surname> <given-names>AG</given-names></string-name></person-group>. <article-title>Predicting protein flexibility through the prediction of local structures</article-title>. <source>Proteins</source>. <year>2011</year>; <volume>79</volume>(<issue>3</issue>):<fpage>839</fpage>–<lpage>52</lpage>. <pub-id pub-id-type="pmid">21287616</pub-id>, doi: <pub-id pub-id-type="doi">10.1002/prot.22922</pub-id>.</mixed-citation></ref>
<ref id="c6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bowman</surname> <given-names>GR</given-names></string-name>, <string-name><surname>Huang</surname> <given-names>X</given-names></string-name>, <string-name><surname>Pande</surname> <given-names>VS</given-names></string-name></person-group>. <article-title>Using generalized ensemble simulations and Markov state models to identify conformational states</article-title>. <source>Methods</source>. <year>2009</year>; <volume>49</volume>(<issue>2</issue>):<fpage>197</fpage>–<lpage>201</lpage>. <pub-id pub-id-type="pmid">19410002</pub-id>, doi: <pub-id pub-id-type="doi">10.1016/j.ymeth.2009.04.013</pub-id>.</mixed-citation></ref>
<ref id="c7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Brooks</surname> <given-names>BR</given-names></string-name>, <string-name><surname>Bruccoleri</surname> <given-names>RE</given-names></string-name>, <string-name><surname>Olafson</surname> <given-names>BD</given-names></string-name>, <string-name><surname>States</surname> <given-names>DJ</given-names></string-name>, <string-name><surname>Swaminathan</surname> <given-names>S</given-names></string-name>, <string-name><surname>Karplus</surname> <given-names>M.</given-names></string-name></person-group> <article-title>CHARMM: A program for macromolecular energy, minimization, and dynamics calculations</article-title>. <source>J Comput Chem</source>. <year>1983</year> <month>Jun</month>; <volume>4</volume>(<issue>2</issue>):<fpage>187</fpage>–<lpage>217</lpage>. <ext-link ext-link-type="uri" xlink:href="https://onlinelibrary.wiley.com/doi/abs/10.1002/jcc.540040211">https://onlinelibrary.wiley.com/doi/abs/10.1002/jcc.540040211</ext-link>, doi: <pub-id pub-id-type="doi">10.1002/jcc.540040211</pub-id>.</mixed-citation></ref>
<ref id="c8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Case</surname> <given-names>DA</given-names></string-name>, <string-name><surname>Aktulga</surname> <given-names>HM</given-names></string-name>, <string-name><surname>Belfon</surname> <given-names>K</given-names></string-name>, <string-name><surname>Cerutti</surname> <given-names>DS</given-names></string-name>, <string-name><surname>Cisneros</surname> <given-names>GA</given-names></string-name>, <string-name><surname>Cruzeiro</surname> <given-names>VWD</given-names></string-name>, <string-name><surname>Forouzesh</surname> <given-names>N</given-names></string-name>, <string-name><surname>Giese</surname> <given-names>TJ</given-names></string-name>, <string-name><surname>Götz</surname> <given-names>AW</given-names></string-name>, <string-name><surname>Gohlke</surname> <given-names>H</given-names></string-name>, <string-name><surname>Izadi</surname> <given-names>S</given-names></string-name>, <string-name><surname>Kasavajhala</surname> <given-names>K</given-names></string-name>, <string-name><surname>Kaymak</surname> <given-names>MC</given-names></string-name>, <string-name><surname>King</surname> <given-names>E</given-names></string-name>, <string-name><surname>Kurtzman</surname> <given-names>T</given-names></string-name>, <string-name><surname>Lee</surname> <given-names>TS</given-names></string-name>, <string-name><surname>Li</surname> <given-names>P</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>J</given-names></string-name>, <string-name><surname>Luchko</surname> <given-names>T</given-names></string-name>, <string-name><surname>Luo</surname> <given-names>R</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>AmberTools</article-title>. <source>J Chem Inf Model</source>. <year>2023</year> <month>Oct</month>; <volume>63</volume>(<issue>20</issue>):<fpage>6183</fpage>–<lpage>6191</lpage>. <pub-id pub-id-type="pmcid">PMC10598796</pub-id>, doi: <pub-id pub-id-type="doi">10.1021/acs.jcim.3c01153</pub-id>.</mixed-citation></ref>
<ref id="c9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cerutti</surname> <given-names>DS</given-names></string-name>, <string-name><surname>Duke</surname> <given-names>RE</given-names></string-name>, <string-name><surname>Darden</surname> <given-names>TA</given-names></string-name>, <string-name><surname>Lybrand</surname> <given-names>TP</given-names></string-name></person-group>. <article-title>Staggered Mesh Ewald: An extension of the Smooth Particle-Mesh Ewald method adding great versatility</article-title>. <source>J Chem Theory Comput</source>. <year>2009</year>; <volume>5</volume>(<issue>9</issue>):<fpage>2322</fpage>. <pub-id pub-id-type="pmid">20174456</pub-id>, doi: <pub-id pub-id-type="doi">10.1021/ct9001015</pub-id>.</mixed-citation></ref>
<ref id="c10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chaudhry</surname> <given-names>SB</given-names></string-name>, <string-name><surname>Veve</surname> <given-names>MP</given-names></string-name>, <string-name><surname>Wagner</surname> <given-names>JL</given-names></string-name></person-group>. <article-title>Cephalosporins: A Focus on Side Chains and beta-Lactam Cross-Reactivity</article-title>. <source>Pharmacy (Basel)</source>. <year>2019</year>; <volume>7</volume>(<issue>3</issue>). <pub-id pub-id-type="pmid">31362351</pub-id>, doi: <pub-id pub-id-type="doi">10.3390/phar-macy7030103</pub-id>.</mixed-citation></ref>
<ref id="c11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname> <given-names>Y</given-names></string-name>, <string-name><surname>McReynolds</surname> <given-names>A</given-names></string-name>, <string-name><surname>Shoichet</surname> <given-names>BK</given-names></string-name></person-group>. <article-title>Re-examining the role of Lys67 in class C beta-lactamase catalysis</article-title>. <source>Protein Sci</source>. <year>2009</year> <month>Mar</month>; <volume>18</volume>(<issue>3</issue>):<fpage>662</fpage>–<lpage>669</lpage>. <pub-id pub-id-type="pmid">19241376</pub-id>, doi: <pub-id pub-id-type="doi">10.1002/pro.60</pub-id>.</mixed-citation></ref>
<ref id="c12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Colque</surname> <given-names>CA</given-names></string-name>, <string-name><surname>Albarracin Orio</surname> <given-names>AG</given-names></string-name>, <string-name><surname>Tomatis</surname> <given-names>PE</given-names></string-name>, <string-name><surname>Dotta</surname> <given-names>G</given-names></string-name>, <string-name><surname>Moreno</surname> <given-names>DM</given-names></string-name>, <string-name><surname>Hedemann</surname> <given-names>LG</given-names></string-name>, <string-name><surname>Hickman</surname> <given-names>RA</given-names></string-name>, <string-name><surname>Sommer</surname> <given-names>LM</given-names></string-name>, <string-name><surname>Feliziani</surname> <given-names>S</given-names></string-name>, <string-name><surname>Moyano</surname> <given-names>AJ</given-names></string-name>, <string-name><surname>Bonomo</surname> <given-names>RA H KJ</given-names></string-name>, <string-name><surname>Molin</surname> <given-names>S</given-names></string-name>, <string-name><surname>Vila</surname> <given-names>AJ</given-names></string-name>, <string-name><surname>Smania</surname> <given-names>AM</given-names></string-name></person-group>. <article-title>Longitudinal Evolution of the Pseudomonas-Derived Cephalosporinase (PDC) Structure and Activity in a Cystic Fibrosis Patient Treated with beta-Lactams</article-title>. <source>mBio</source>. <year>2022</year>; <volume>13</volume>(<issue>5</issue>):<fpage>e0166322</fpage>. <pub-id pub-id-type="pmid">36073814</pub-id>, doi: <pub-id pub-id-type="doi">10.1128/mbio.01663-22</pub-id>.</mixed-citation></ref>
<ref id="c13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Crichlow</surname> <given-names>GV</given-names></string-name>, <string-name><surname>Kuzin</surname> <given-names>AP</given-names></string-name>, <string-name><surname>Nukaga</surname> <given-names>M</given-names></string-name>, <string-name><surname>Mayama</surname> <given-names>K</given-names></string-name>, <string-name><surname>Sawai</surname> <given-names>T</given-names></string-name>, <string-name><surname>Knox</surname> <given-names>JR</given-names></string-name></person-group>. <article-title>Structure of the extended-spectrum class C betalactamase of Enterobacter cloacae GC1, a natural mutant with a tandem tripeptide insertion</article-title>. <source>Biochemistry</source>. <year>1999</year>; <volume>38</volume>(<issue>32</issue>):<fpage>10256</fpage>–<lpage>61</lpage>. <pub-id pub-id-type="pmid">10441119</pub-id>, doi: <pub-id pub-id-type="doi">10.1021/bi9908787</pub-id>.</mixed-citation></ref>
<ref id="c14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Crichlow</surname> <given-names>GV</given-names></string-name>, <string-name><surname>Nukaga</surname> <given-names>M</given-names></string-name>, <string-name><surname>Doppalapudi</surname> <given-names>VR</given-names></string-name>, <string-name><surname>Buynak</surname> <given-names>JD</given-names></string-name>, <string-name><surname>Knox</surname> <given-names>JR</given-names></string-name></person-group>. <article-title>Inhibition of class C beta-lactamases: structure of a reaction intermediate with a cephem sulfone</article-title>. <source>Biochemistry</source>. <year>2001</year>; <volume>40</volume>(<issue>21</issue>):<fpage>6233</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="pmid">11371184</pub-id>, doi: <pub-id pub-id-type="doi">10.1021/bi010131s</pub-id>.</mixed-citation></ref>
<ref id="c15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Curran</surname> <given-names>CS</given-names></string-name>, <string-name><surname>Bolig</surname> <given-names>T</given-names></string-name>, <string-name><surname>Torabi-Parizi</surname> <given-names>P.</given-names></string-name></person-group> <article-title>Mechanisms and Targeted Therapies for Pseudomonas aeruginosa Lung Infection</article-title>. <source>Am J Respir Crit Care Med</source>. <year>2018</year>; <volume>197</volume>(<issue>6</issue>):<fpage>708</fpage>–<lpage>727</lpage>. <pub-id pub-id-type="pmid">29087211</pub-id>, doi: <pub-id pub-id-type="doi">10.1164/rccm.201705-1043SO</pub-id>.</mixed-citation></ref>
<ref id="c16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Doerr</surname> <given-names>S</given-names></string-name>, <string-name><surname>Harvey</surname> <given-names>MJ</given-names></string-name>, <string-name><surname>Noe</surname> <given-names>F</given-names></string-name>, <string-name><surname>De Fabritiis</surname> <given-names>G.</given-names></string-name></person-group> <article-title>HTMD: High-Throughput Molecular Dynamics for Molecular Discovery</article-title>. <source>J Chem Theory Comput</source>. <year>2016</year>; <volume>12</volume>(<issue>4</issue>):<fpage>1845</fpage>–<lpage>52</lpage>. <pub-id pub-id-type="pmid">26949976</pub-id>, doi: <pub-id pub-id-type="doi">10.1021/acs.jctc.6b00049</pub-id>.</mixed-citation></ref>
<ref id="c17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Feenstra</surname> <given-names>KA</given-names></string-name>, <string-name><surname>Hess</surname> <given-names>B</given-names></string-name>, <string-name><surname>Berendsen</surname> <given-names>HJC</given-names></string-name></person-group>. <article-title>Improving effciency of large time-scale molecular dynamics simulations of hydrogen-rich systems</article-title>. <source>journal of Computational Chemistry</source>. <year>1999</year>; <volume>20</volume>(<issue>8</issue>):<fpage>786</fpage>–<lpage>798</lpage>. doi: <pub-id pub-id-type="doi">10.1002/(sici)1096-987x(199906)20:8&lt;786::Aid-jcc5&gt;3.0.Co;2-b</pub-id>.</mixed-citation></ref>
<ref id="c18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Golemi-Kotra</surname> <given-names>D</given-names></string-name>, <string-name><surname>Meroueh</surname> <given-names>SO</given-names></string-name>, <string-name><surname>Kim</surname> <given-names>C</given-names></string-name>, <string-name><surname>Vakulenko</surname> <given-names>SB</given-names></string-name>, <string-name><surname>Bulychev</surname> <given-names>A</given-names></string-name>, <string-name><surname>Stemmler</surname> <given-names>AJ</given-names></string-name>, <string-name><surname>Stemmler</surname> <given-names>TL</given-names></string-name>, <string-name><surname>Mobashery</surname> <given-names>S.</given-names></string-name></person-group> <article-title>The importance of a critical protonation state and the fate of the catalytic steps in class A beta-lactamases and penicillin-binding proteins</article-title>. <source>J Biol Chem</source>. <year>2004</year> <month>Aug</month>; <volume>279</volume>(<issue>33</issue>):<fpage>34665</fpage>–<lpage>34673</lpage>. <pub-id pub-id-type="pmid">15152012</pub-id>, doi: <pub-id pub-id-type="doi">10.1074/jbc.M313143200</pub-id>.</mixed-citation></ref>
<ref id="c19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Guerra</surname> <given-names>JVdS</given-names></string-name>, <string-name><surname>Ribeiro Filho</surname> <given-names>HV</given-names></string-name>, <string-name><surname>Bortot</surname> <given-names>LO</given-names></string-name>, <string-name><surname>Honorato</surname> <given-names>RV</given-names></string-name>, <string-name><surname>Pereira</surname> <given-names>JGdC</given-names></string-name>, <string-name><surname>Lopes-de Oliveira</surname> <given-names>PS</given-names></string-name></person-group>. <article-title>ParKVFinder: A thread-level parallel approach in biomolecular cavity detection</article-title>. <source>SoftwareX</source>. <year>2020</year>; <volume>12</volume>. <ext-link ext-link-type="uri" xlink:href="https://www.sciencedirect.com/science/article/pii/S2352711020303198">https://www.sciencedirect.com/science/article/pii/S2352711020303198</ext-link>, doi: <pub-id pub-id-type="doi">10.1016/j.softx.2020.100606</pub-id>.</mixed-citation></ref>
<ref id="c20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Harvey</surname> <given-names>MJ</given-names></string-name>, <string-name><surname>Giupponi</surname> <given-names>G</given-names></string-name>, <string-name><surname>Fabritiis</surname> <given-names>GD</given-names></string-name></person-group>. <article-title>ACEMD: Accelerating Biomolecular Dynamics in the Microsecond Time Scale</article-title>. <source>J Chem Theory Comput</source>. <year>2009</year>; <volume>5</volume>(<issue>6</issue>):<fpage>1632</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="pmid">26609855</pub-id>, doi: <pub-id pub-id-type="doi">10.1021/ct9000685</pub-id>.</mixed-citation></ref>
<ref id="c21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hollingsworth</surname> <given-names>SA</given-names></string-name>, <string-name><surname>Dror</surname> <given-names>RO</given-names></string-name></person-group>. <article-title>Molecular Dynamics Simulation for All</article-title>. <source>Neuron</source>. <year>2018</year>; <volume>99</volume>(<issue>6</issue>):<fpage>1129</fpage>–<lpage>1143</lpage>. <pub-id pub-id-type="pmid">30236283</pub-id>, doi: <pub-id pub-id-type="doi">10.1016/j.neuron.2018.08.011</pub-id>.</mixed-citation></ref>
<ref id="c22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Horcajada</surname> <given-names>JP</given-names></string-name>, <string-name><surname>Montero</surname> <given-names>M</given-names></string-name>, <string-name><surname>Oliver</surname> <given-names>A</given-names></string-name>, <string-name><surname>Sorli</surname> <given-names>L</given-names></string-name>, <string-name><surname>Luque</surname> <given-names>S</given-names></string-name>, <string-name><surname>Gomez-Zorrilla</surname> <given-names>S</given-names></string-name>, <string-name><surname>Benito</surname> <given-names>N</given-names></string-name>, <string-name><surname>Grau</surname> <given-names>S.</given-names></string-name></person-group> <article-title>Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections</article-title>. <source>Clin Microbiol Rev</source>. <year>2019</year>; <volume>32</volume>(<issue>4</issue>). <pub-id pub-id-type="pmid">31462403</pub-id>, doi: <pub-id pub-id-type="doi">10.1128/CMR.00031-19</pub-id>.</mixed-citation></ref>
<ref id="c23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Husic</surname> <given-names>BE</given-names></string-name>, <string-name><surname>Pande</surname> <given-names>VS</given-names></string-name></person-group>. <article-title>Markov State Models: From an Art to a Science</article-title>. <source>J Am Chem Soc</source>. <year>2018</year>; <volume>140</volume>(<issue>7</issue>):<fpage>2386</fpage>–<lpage>2396</lpage>. <pub-id pub-id-type="pmid">29323881</pub-id>, doi: <pub-id pub-id-type="doi">10.1021/jacs.7b12191</pub-id>.</mixed-citation></ref>
<ref id="c24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jacoby</surname> <given-names>GA</given-names></string-name></person-group>. <article-title>AmpC beta-lactamases</article-title>. <source>Clin Microbiol Rev</source>. <year>2009</year>; <volume>22</volume>(<issue>1</issue>):<fpage>161</fpage>–<lpage>82</lpage>. <pub-id pub-id-type="pmid">19136439</pub-id>, doi: <pub-id pub-id-type="doi">10.1128/CMR.00036-08</pub-id>.</mixed-citation></ref>
<ref id="c25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jurado-Martin</surname> <given-names>I</given-names></string-name>, <string-name><surname>Sainz-Mejias</surname> <given-names>M</given-names></string-name>, <string-name><surname>McClean</surname> <given-names>S.</given-names></string-name></person-group> <article-title>Pseudomonas aeruginosa: An Audacious Pathogen with an Adaptable Arsenal of Virulence Factors</article-title>. <source>Int J Mol Sci</source>. <year>2021</year>; <volume>22</volume>(<issue>6</issue>). <pub-id pub-id-type="pmid">33803907</pub-id>, doi: <pub-id pub-id-type="doi">10.3390/ijms22063128</pub-id>.</mixed-citation></ref>
<ref id="c26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kerr</surname> <given-names>KG</given-names></string-name>, <string-name><surname>Snelling</surname> <given-names>AM</given-names></string-name></person-group>. <article-title>Pseudomonas aeruginosa: a formidable and ever-present adversary</article-title>. <source>J Hosp Infect</source>. <year>2009</year>; <volume>73</volume>(<issue>4</issue>):<fpage>338</fpage>–<lpage>44</lpage>. <pub-id pub-id-type="pmid">19699552</pub-id>, doi: <pub-id pub-id-type="doi">10.1016/j.jhin.2009.04.020</pub-id>.</mixed-citation></ref>
<ref id="c27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kim</surname> <given-names>MO</given-names></string-name>, <string-name><surname>Blachly</surname> <given-names>PG</given-names></string-name>, <string-name><surname>Kaus</surname> <given-names>JW</given-names></string-name>, <string-name><surname>McCammon</surname> <given-names>JA</given-names></string-name></person-group>. <article-title>Protocols utilizing constant pH molecular dynamics to compute pH-dependent binding free energies</article-title>. <source>J Phys Chem B</source>. <year>2015</year> <month>Jan</month>; <volume>119</volume>(<issue>3</issue>):<fpage>861</fpage>–<lpage>872</lpage>. <pub-id pub-id-type="pmid">25134690</pub-id>, doi: <pub-id pub-id-type="doi">10.1021/jp505777n</pub-id>.</mixed-citation></ref>
<ref id="c28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lahiri</surname> <given-names>SD</given-names></string-name>, <string-name><surname>Mangani</surname> <given-names>S</given-names></string-name>, <string-name><surname>Durand-Reville</surname> <given-names>T</given-names></string-name>, <string-name><surname>Benvenuti</surname> <given-names>M</given-names></string-name>, <string-name><surname>De Luca</surname> <given-names>F</given-names></string-name>, <string-name><surname>Sanyal</surname> <given-names>G</given-names></string-name>, <string-name><surname>Docquier</surname> <given-names>JD</given-names></string-name></person-group>. <article-title>Structural insight into potent broad-spectrum inhibition with reversible recyclization mechanism: avibactam in complex with CTX-M-15 and Pseudomonas aeruginosa AmpC beta-lactamases</article-title>. <source>Antimicrob Agents Chemother</source>. <year>2013</year>; <volume>57</volume>(<issue>6</issue>):<fpage>2496</fpage>– <lpage>505</lpage>. <pub-id pub-id-type="pmid">23439634</pub-id>, doi: <pub-id pub-id-type="doi">10.1128/AAC.02247-12</pub-id>.</mixed-citation></ref>
<ref id="c29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lahiri</surname> <given-names>SD</given-names></string-name>, <string-name><surname>Walkup</surname> <given-names>GK</given-names></string-name>, <string-name><surname>Whiteaker</surname> <given-names>JD</given-names></string-name>, <string-name><surname>Palmer</surname> <given-names>T</given-names></string-name>, <string-name><surname>McCormack</surname> <given-names>K</given-names></string-name>, <string-name><surname>Tanudra</surname> <given-names>MA</given-names></string-name>, <string-name><surname>Nash</surname> <given-names>TJ</given-names></string-name>, <string-name><surname>Thresher</surname> <given-names>J</given-names></string-name>, <string-name><surname>Johnstone</surname> <given-names>MR</given-names></string-name>, <string-name><surname>Hajec</surname> <given-names>L</given-names></string-name>, <string-name><surname>Livchak</surname> <given-names>S</given-names></string-name>, <string-name><surname>McLaughlin</surname> <given-names>RE</given-names></string-name>, <string-name><surname>Alm</surname> <given-names>RA</given-names></string-name></person-group>. <article-title>Selection and molecular characterization of ceftazidime/avibactam-resistant mutants in Pseudomonas aeruginosa strains containing derepressed AmpC</article-title>. <source>J Antimicrob Chemother</source>. <year>2015</year>; <volume>70</volume>(<issue>6</issue>):<fpage>1650</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="pmid">25645206</pub-id>, doi: <pub-id pub-id-type="doi">10.1093/jac/dkv004</pub-id>.</mixed-citation></ref>
<ref id="c30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lima</surname> <given-names>LM</given-names></string-name>, <string-name><surname>Silva</surname> <given-names>B</given-names></string-name>, <string-name><surname>Barbosa</surname> <given-names>G</given-names></string-name>, <string-name><surname>Barreiro</surname> <given-names>EJ</given-names></string-name></person-group>. <article-title>beta-lactam antibiotics: An overview from a medicinal chemistry perspective</article-title>. <source>Eur J Med Chem</source>. <year>2020</year>; <volume>208</volume>:<fpage>112829</fpage>. <pub-id pub-id-type="pmid">33002736</pub-id>, doi: <pub-id pub-id-type="doi">10.1016/j.ejmech.2020.112829</pub-id>.</mixed-citation></ref>
<ref id="c31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mack</surname> <given-names>AR</given-names></string-name>, <string-name><surname>Barnes</surname> <given-names>MD</given-names></string-name>, <string-name><surname>Taracila</surname> <given-names>MA</given-names></string-name>, <string-name><surname>Hujer</surname> <given-names>AM</given-names></string-name>, <string-name><surname>Hujer</surname> <given-names>KM</given-names></string-name>, <string-name><surname>Cabot</surname> <given-names>G</given-names></string-name>, <string-name><surname>Feldgarden</surname> <given-names>M</given-names></string-name>, <string-name><surname>Haft</surname> <given-names>DH</given-names></string-name>, <string-name><surname>Klimke</surname> <given-names>W</given-names></string-name>, <string-name><surname>van den Akker</surname> <given-names>F</given-names></string-name>, <string-name><surname>Vila</surname> <given-names>AJ</given-names></string-name>, <string-name><surname>Smania</surname> <given-names>A</given-names></string-name>, <string-name><surname>Haider</surname> <given-names>S</given-names></string-name>, <string-name><surname>Papp-Wallace</surname> <given-names>KM</given-names></string-name>, <string-name><surname>Bradford</surname> <given-names>PA</given-names></string-name>, <string-name><surname>Rossolini</surname> <given-names>GM</given-names></string-name>, <string-name><surname>Docquier</surname> <given-names>JD</given-names></string-name>, <string-name><surname>Frère</surname> <given-names>JM</given-names></string-name>, <string-name><surname>Galleni</surname> <given-names>M</given-names></string-name>, <string-name><surname>Hanson</surname> <given-names>ND</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>A standard numbering scheme for class C /3-lactamases</article-title>. <source>Antimicrob Agents Chemother</source>. <year>2020</year> <month>Feb</month>; <volume>64</volume>(<issue>3</issue>). <pub-id pub-id-type="pmcid">PMC7038257</pub-id>, doi: <pub-id pub-id-type="doi">10.1128/aac.01841-19</pub-id>.</mixed-citation></ref>
<ref id="c32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Maier</surname> <given-names>JA</given-names></string-name>, <string-name><surname>Martinez</surname> <given-names>C</given-names></string-name>, <string-name><surname>Kasavajhala</surname> <given-names>K</given-names></string-name>, <string-name><surname>Wickstrom</surname> <given-names>L</given-names></string-name>, <string-name><surname>Hauser</surname> <given-names>KE</given-names></string-name>, <string-name><surname>Simmerling</surname> <given-names>C.</given-names></string-name></person-group> <article-title>ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB</article-title>. <source>J Chem Theory Comput</source>. <year>2015</year>; <volume>11</volume>(<issue>8</issue>):<fpage>3696</fpage>–<lpage>713</lpage>. <pub-id pub-id-type="pmid">26574453</pub-id>, doi: <pub-id pub-id-type="doi">10.1021/acs.jctc.5b00255</pub-id>.</mixed-citation></ref>
<ref id="c33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Malhotra</surname> <given-names>S</given-names></string-name>, <string-name><surname>Hayes</surname> <given-names>J D</given-names></string-name>, <string-name><surname>Wozniak</surname> <given-names>DJ</given-names></string-name></person-group>. <article-title>Cystic Fibrosis and Pseudomonas aeruginosa: the Host-Microbe Interface</article-title>. <source>Clin Microbiol Rev</source>. <year>2019</year>; <volume>32</volume>(<issue>3</issue>). <pub-id pub-id-type="pmid">31142499</pub-id>, doi: <pub-id pub-id-type="doi">10.1128/CMR.00138-18</pub-id>.</mixed-citation></ref>
<ref id="c34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Martinez</surname> <given-names>L.</given-names></string-name></person-group> <article-title>Automatic identification of mobile and rigid substructures in molecular dynamics simulations and fractional structural fluctuation analysis</article-title>. <source>PLoS One</source>. <year>2015</year>; <volume>10</volume>(<issue>3</issue>):<fpage>e0119264</fpage>. <pub-id pub-id-type="pmid">25816325</pub-id>, doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0119264</pub-id>.</mixed-citation></ref>
<ref id="c35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>McGibbon</surname> <given-names>RT</given-names></string-name>, <string-name><surname>Beauchamp</surname> <given-names>KA</given-names></string-name>, <string-name><surname>Harrigan</surname> <given-names>MP</given-names></string-name>, <string-name><surname>Klein</surname> <given-names>C</given-names></string-name>, <string-name><surname>Swails</surname> <given-names>JM</given-names></string-name>, <string-name><surname>Heandez</surname> <given-names>CX</given-names></string-name>, <string-name><surname>Schwantes</surname> <given-names>CR</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>LP</given-names></string-name>, <string-name><surname>Lane</surname> <given-names>TJ</given-names></string-name>, <string-name><surname>Pande</surname> <given-names>VS</given-names></string-name></person-group>. <article-title>MDTraj: A Mode Open Library for the Analysis of Molecular Dynamics Trajectories</article-title>. <source>Biophys J</source>. <year>2015</year>; <volume>109</volume>(<issue>8</issue>):<fpage>1528</fpage>–<lpage>32</lpage>. <pub-id pub-id-type="pmid">26488642</pub-id>, doi: <pub-id pub-id-type="doi">10.1016/j.bpj.2015.08.015</pub-id>.</mixed-citation></ref>
<ref id="c36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Meroueh</surname> <given-names>SO</given-names></string-name>, <string-name><surname>Fisher</surname> <given-names>JF</given-names></string-name>, <string-name><surname>Schlegel</surname> <given-names>HB</given-names></string-name>, <string-name><surname>Mobashery</surname> <given-names>S.</given-names></string-name></person-group> <article-title>Ab initio QM/MM study of class A beta-lactamase acylation: dual participation of Glu166 and Lys73 in a concerted base promotion of Ser70</article-title>. <source>J Am Chem Soc</source>. <year>2005</year>; <volume>127</volume>(<issue>44</issue>):<fpage>15397</fpage>–<lpage>407</lpage>. <pub-id pub-id-type="pmid">16262403</pub-id>, doi: <pub-id pub-id-type="doi">10.1021/ja051592u</pub-id>.</mixed-citation></ref>
<ref id="c37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mongan</surname> <given-names>J</given-names></string-name>, <string-name><surname>Case</surname> <given-names>DA</given-names></string-name>, <string-name><surname>McCammon</surname> <given-names>JA</given-names></string-name></person-group>. <article-title>Constant pH molecular dynamics in generalized Born implicit solvent</article-title>. <source>J Comput Chem</source>. <year>2004</year> <month>Dec</month>; <volume>25</volume>(<issue>16</issue>):<fpage>2038</fpage>–<lpage>2048</lpage>. <pub-id pub-id-type="pmid">15481090</pub-id>, doi: <pub-id pub-id-type="doi">10.1002/jcc.20139</pub-id>.</mixed-citation></ref>
<ref id="c38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mora-Ochomogo</surname> <given-names>M</given-names></string-name>, <string-name><surname>Lohans</surname> <given-names>CT</given-names></string-name></person-group>. <article-title>beta-Lactam antibiotic targets and resistance mechanisms: from covalent inhibitors to substrates</article-title>. <source>RSC Med Chem</source>. <year>2021</year>; <volume>12</volume>(<issue>10</issue>):<fpage>1623</fpage>–<lpage>1639</lpage>. <pub-id pub-id-type="pmid">34778765</pub-id>, doi: <pub-id pub-id-type="doi">10.1039/d1md00200g</pub-id>.</mixed-citation></ref>
<ref id="c39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Munita</surname> <given-names>JM</given-names></string-name>, <string-name><surname>Arias</surname> <given-names>CA</given-names></string-name></person-group>. <article-title>Mechanisms of Antibiotic Resistance</article-title>. <source>Microbiol Spectr</source>. <year>2016</year>; <volume>4</volume>(<issue>2</issue>). <pub-id pub-id-type="pmid">27227291</pub-id>, doi: <pub-id pub-id-type="doi">10.1128/microbiolspec.VMBF-0016-2015</pub-id>.</mixed-citation></ref>
<ref id="c40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nordmann</surname> <given-names>P</given-names></string-name>, <string-name><surname>Mammeri</surname> <given-names>H.</given-names></string-name></person-group> <article-title>Extended-spectrum cephalosporinases: structure, detection and epidemiology</article-title>. <source>Future Microbiol</source>. <year>2007</year>; <volume>2</volume>(<issue>3</issue>):<fpage>297</fpage>–<lpage>307</lpage>. <pub-id pub-id-type="pmid">17661704</pub-id>, doi: <pub-id pub-id-type="doi">10.2217/17460913.2.3.297</pub-id>.</mixed-citation></ref>
<ref id="c41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Olsson</surname> <given-names>MH</given-names></string-name>, <string-name><surname>Sondergaard</surname> <given-names>CR</given-names></string-name>, <string-name><surname>Rostkowski</surname> <given-names>M</given-names></string-name>, <string-name><surname>Jensen</surname> <given-names>JH</given-names></string-name></person-group>. <article-title>PROPKA3: Consistent Treatment of Inteal and Surface Residues in Empirical pKa Predictions</article-title>. <source>J Chem Theory Comput</source>. <year>2011</year>; <volume>7</volume>(<issue>2</issue>):<fpage>525</fpage>–<lpage>37</lpage>. <pub-id pub-id-type="pmid">26596171</pub-id>, doi: <pub-id pub-id-type="doi">10.1021/ct100578z</pub-id>.</mixed-citation></ref>
<ref id="c42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pang</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Raudonis</surname> <given-names>R</given-names></string-name>, <string-name><surname>Glick</surname> <given-names>BR</given-names></string-name>, <string-name><surname>Lin</surname> <given-names>TJ</given-names></string-name>, <string-name><surname>Cheng</surname> <given-names>Z.</given-names></string-name></person-group> <article-title>Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alteative therapeutic strategies</article-title>. <source>Biotechnol Adv</source>. <year>2019</year>; <volume>37</volume>(<issue>1</issue>):<fpage>177</fpage>–<lpage>192</lpage>. <pub-id pub-id-type="pmid">30500353</pub-id>, doi: <pub-id pub-id-type="doi">10.1016/j.biotechadv.2018.11.013</pub-id>.</mixed-citation></ref>
<ref id="c43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pemberton</surname> <given-names>OA</given-names></string-name>, <string-name><surname>Noor</surname> <given-names>RE</given-names></string-name>, <string-name><surname>Kumar</surname> <given-names>MVV</given-names></string-name>, <string-name><surname>Sanishvili</surname> <given-names>R</given-names></string-name>, <string-name><surname>Kemp</surname> <given-names>MT</given-names></string-name>, <string-name><surname>Keas</surname> <given-names>FL</given-names></string-name>, <string-name><surname>Woodcock</surname> <given-names>HL</given-names></string-name>, <string-name><surname>Gelis</surname> <given-names>I</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>Y.</given-names></string-name></person-group> <article-title>Mechanism of proton transfer in class A beta-lactamase catalysis and inhibition by avibactam</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2020</year>; <volume>117</volume>(<issue>11</issue>):<fpage>5818</fpage>–<lpage>5825</lpage>. <pub-id pub-id-type="pmid">32123084</pub-id>, doi: <pub-id pub-id-type="doi">10.1073/pnas.1922203117</pub-id>.</mixed-citation></ref>
<ref id="c44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Peng</surname> <given-names>Jh</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>W</given-names></string-name>, <string-name><given-names>Yu</given-names> <surname>Yq</surname></string-name>, <string-name><given-names>Gu</given-names> <surname>Hl</surname></string-name>, <string-name><surname>Huang</surname> <given-names>X.</given-names></string-name></person-group> <article-title>Clustering algorithms to analyze molecular dynamics simulation trajectories for complex chemical and biological systems</article-title>. <source>Chinese journal of Chemical Physics</source>. <year>2018</year>; <volume>31</volume>(<issue>4</issue>):<fpage>404</fpage>–<lpage>420</lpage>. <ext-link ext-link-type="uri" xlink:href="https://pubs.aip.org/cps/cjcp/article-abstract/31/4/404/1059787/Clustering-algorithms-to-analyze-molecular?redirectedFrom=fulltext">https://pubs.aip.org/cps/cjcp/article-abstract/31/4/404/1059787/Clustering-algorithms-to-analyze-molecular?redirectedFrom=fulltext</ext-link>, doi: <pub-id pub-id-type="doi">10.1063/1674-0068/31/cjcp1806147</pub-id>.</mixed-citation></ref>
<ref id="c45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pérez</surname> <given-names>A</given-names></string-name>, <string-name><surname>Herrera-Nieto</surname> <given-names>P</given-names></string-name>, <string-name><surname>Doerr</surname> <given-names>S</given-names></string-name>, <string-name><surname>De Fabritiis</surname> <given-names>G.</given-names></string-name></person-group> <article-title>AdaptiveBandit: A multi-armed bandit framework for adaptive sampling in molecular simulations</article-title>. <source>J Chem Theory Comput</source>. <year>2020</year> <month>Jul</month>; <volume>16</volume>(<issue>7</issue>):<fpage>4685</fpage>–<lpage>4693</lpage>. <pub-id pub-id-type="pmid">32539384</pub-id>, doi: <pub-id pub-id-type="doi">10.1021/acs.jctc.0c00205</pub-id>.</mixed-citation></ref>
<ref id="c46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Perez-Heandez</surname> <given-names>G</given-names></string-name>, <string-name><surname>Noe</surname> <given-names>F.</given-names></string-name></person-group> <article-title>Hierarchical Time-Lagged Independent Component Analysis: Computing Slow Modes and Reaction Coordinates for Large Molecular Systems</article-title>. <source>J Chem Theory Comput</source>. <year>2016</year>; <volume>12</volume>(<issue>12</issue>):<fpage>6118</fpage>–<lpage>6129</lpage>. <pub-id pub-id-type="pmid">27792332</pub-id>, doi: <pub-id pub-id-type="doi">10.1021/acs.jctc.6b00738</pub-id>.</mixed-citation></ref>
<ref id="c47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Perez-Inestrosa</surname> <given-names>E</given-names></string-name>, <string-name><surname>Suau</surname> <given-names>R</given-names></string-name>, <string-name><surname>Montanez</surname> <given-names>MI</given-names></string-name>, <string-name><surname>Rodriguez</surname> <given-names>R</given-names></string-name>, <string-name><surname>Mayorga</surname> <given-names>C</given-names></string-name>, <string-name><surname>Torres</surname> <given-names>MJ</given-names></string-name>, <string-name><surname>Blanca</surname> <given-names>M.</given-names></string-name></person-group> <article-title>Cephalosporin chemical reactivity and its immunological implications</article-title>. <source>Curr Opin Allergy Clin Immunol</source>. <year>2005</year>; <volume>5</volume>(<issue>4</issue>):<fpage>323</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="pmid">15985814</pub-id>, doi: <pub-id pub-id-type="doi">10.1097/01.all.0000173788.73401.69</pub-id>.</mixed-citation></ref>
<ref id="c48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Philippon</surname> <given-names>A</given-names></string-name>, <string-name><surname>Arlet</surname> <given-names>G</given-names></string-name>, <string-name><surname>Labia</surname> <given-names>R</given-names></string-name>, <string-name><surname>Iorga</surname> <given-names>BI</given-names></string-name></person-group>. <article-title>Class C beta-Lactamases: Molecular Characteristics</article-title>. <source>Clin Microbiol Rev</source>. <year>2022</year>; <volume>35</volume>(<issue>3</issue>):<fpage>e0015021</fpage>. <pub-id pub-id-type="pmid">35435729</pub-id>, doi: <pub-id pub-id-type="doi">10.1128/cmr.00150-21</pub-id>.</mixed-citation></ref>
<ref id="c49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Polizzi</surname> <given-names>NF</given-names></string-name>, <string-name><surname>Therien</surname> <given-names>MJ</given-names></string-name>, <string-name><surname>Beratan</surname> <given-names>DN</given-names></string-name></person-group>. <article-title>Mean First-Passage Times in Biology</article-title>. <source>Isr J Chem</source>. <year>2016</year>; <volume>56</volume>(<issue>9–10</issue>):<fpage>816</fpage>–<lpage>824</lpage>. <pub-id pub-id-type="pmid">29081538</pub-id>, doi: <pub-id pub-id-type="doi">10.1002/ijch.201600040</pub-id>.</mixed-citation></ref>
<ref id="c50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Powers</surname> <given-names>RA</given-names></string-name>, <string-name><surname>Shoichet</surname> <given-names>BK</given-names></string-name></person-group>. <article-title>Structure-based approach for binding site identification on AmpC beta-lactamase</article-title>. <source>J Med Chem</source>. <year>2002</year>; <volume>45</volume>(<issue>15</issue>):<fpage>3222</fpage>–<lpage>34</lpage>. <pub-id pub-id-type="pmid">12109906</pub-id>, doi: <pub-id pub-id-type="doi">10.1021/jm020002p</pub-id>.</mixed-citation></ref>
<ref id="c51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Prabantu</surname> <given-names>VM</given-names></string-name>, <string-name><surname>Gadiyaram</surname> <given-names>V</given-names></string-name>, <string-name><surname>Vishveshwara</surname> <given-names>S</given-names></string-name>, <string-name><surname>Srinivasan</surname> <given-names>N.</given-names></string-name></person-group> <article-title>Understanding structural variability in proteins using protein structural networks</article-title>. <source>Curr Res Struct Biol</source>. <year>2022</year>; <volume>4</volume>:<fpage>134</fpage>–<lpage>145</lpage>. <pub-id pub-id-type="pmid">35586857</pub-id>, doi: <pub-id pub-id-type="doi">10.1016/j.crstbi.2022.04.002</pub-id>.</mixed-citation></ref>
<ref id="c52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Reynolds</surname> <given-names>D</given-names></string-name>, <string-name><surname>Kollef</surname> <given-names>M.</given-names></string-name></person-group> <article-title>The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An Update</article-title>. <source>Drugs</source>. <year>2021</year>; <volume>81</volume>(<issue>18</issue>):<fpage>2117</fpage>–<lpage>2131</lpage>. <pub-id pub-id-type="pmid">34743315</pub-id>, doi: <pub-id pub-id-type="doi">10.1007/s40265-021-01635-6</pub-id>.</mixed-citation></ref>
<ref id="c53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rodriguez-Martinez</surname> <given-names>JM</given-names></string-name>, <string-name><surname>Poirel</surname> <given-names>L</given-names></string-name>, <string-name><surname>Nordmann</surname> <given-names>P.</given-names></string-name></person-group> <article-title>Genetic and functional variability of AmpC-type betalactamases from Acinetobacter baumannii</article-title>. <source>Antimicrob Agents Chemother</source>. <year>2010</year>; <volume>54</volume>(<issue>11</issue>):<fpage>4930</fpage>–<lpage>3</lpage>. <pub-id pub-id-type="pmid">20713667</pub-id>, doi: <pub-id pub-id-type="doi">10.1128/AAC.00427-10</pub-id>.</mixed-citation></ref>
<ref id="c54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Roe</surname> <given-names>DR</given-names></string-name>, <string-name><surname>Cheatham</surname> <given-names>TE</given-names> <suffix>3rd</suffix></string-name></person-group>. <article-title>PTRAJ and CPPTRAJ: Software for processing and analysis of molecular dynamics trajectory data</article-title>. <source>J Chem Theory Comput</source>. <year>2013</year> <month>Jul</month>; <volume>9</volume>(<issue>7</issue>):<fpage>3084</fpage>–<lpage>3095</lpage>. <pub-id pub-id-type="pmid">26583988</pub-id>, doi: <pub-id pub-id-type="doi">10.1021/ct400341p</pub-id>.</mixed-citation></ref>
<ref id="c55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ruedas-Lopez</surname> <given-names>A</given-names></string-name>, <string-name><surname>Alonso-Garcia</surname> <given-names>I</given-names></string-name>, <string-name><surname>Lasarte-Monterrubio</surname> <given-names>C</given-names></string-name>, <string-name><surname>Guijarro-Sanchez</surname> <given-names>P</given-names></string-name>, <string-name><surname>Gato</surname> <given-names>E</given-names></string-name>, <string-name><surname>Vazquez-Ucha</surname> <given-names>JC</given-names></string-name>, <string-name><surname>Vallejo</surname> <given-names>JA</given-names></string-name>, <string-name><surname>Fraile-Ribot</surname> <given-names>PA</given-names></string-name>, <string-name><surname>Feandez-Perez</surname> <given-names>B</given-names></string-name>, <string-name><surname>Velasco</surname> <given-names>D</given-names></string-name>, <string-name><surname>Gutierrez-Urbon</surname> <given-names>JM</given-names></string-name>, <string-name><surname>Oviano</surname> <given-names>M</given-names></string-name>, <string-name><surname>Beceiro</surname> <given-names>A</given-names></string-name>, <string-name><surname>Gonzalez-Bello</surname> <given-names>C</given-names></string-name>, <string-name><surname>Oliver</surname> <given-names>A</given-names></string-name>, <string-name><surname>Arca-Suarez</surname> <given-names>J</given-names></string-name>, <string-name><surname>Bou</surname> <given-names>G.</given-names></string-name></person-group> <article-title>Selection of AmpC beta-Lactamase Variants and Metallo-beta-Lactamases Leading to Ceftolozane/Tazobactam and Ceftazidime/Avibactam Resistance during Treatment of MDR/XDR Pseudomonas aeruginosa Infections</article-title>. <source>Antimicrob Agents Chemother</source>. <year>2022</year>; <volume>66</volume>(<issue>2</issue>):<fpage>e0206721</fpage>. <pub-id pub-id-type="pmid">34930034</pub-id>, doi: <pub-id pub-id-type="doi">10.1128/AAC.02067-21</pub-id>.</mixed-citation></ref>
<ref id="c56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Scherer</surname> <given-names>MK</given-names></string-name>, <string-name><surname>Trendelkamp-Schroer</surname> <given-names>B</given-names></string-name>, <string-name><surname>Paul</surname> <given-names>F</given-names></string-name>, <string-name><surname>Perez-Heandez</surname> <given-names>G</given-names></string-name>, <string-name><surname>Hoffmann</surname> <given-names>M</given-names></string-name>, <string-name><surname>Plattner</surname> <given-names>N</given-names></string-name>, <string-name><surname>Wehmeyer</surname> <given-names>C</given-names></string-name>, <string-name><surname>Prinz</surname> <given-names>JH</given-names></string-name>, <string-name><surname>Noe</surname> <given-names>F.</given-names></string-name></person-group> <article-title>PyEMMA 2: A Software Package for Estimation, Validation, and Analysis of Markov Models</article-title>. <source>J Chem Theory Comput</source>. <year>2015</year>; <volume>11</volume>(<issue>11</issue>):<fpage>5525</fpage>–<lpage>42</lpage>. <pub-id pub-id-type="pmid">26574340</pub-id>, doi: <pub-id pub-id-type="doi">10.1021/acs.jctc.5b00743</pub-id>.</mixed-citation></ref>
<ref id="c57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schlegel</surname> <given-names>HB</given-names></string-name></person-group>. <article-title>Optimization of equilibrium geometries and transition structures</article-title>. <source>J Comput Chem</source>. <year>1982</year> <month>Jun</month>; <volume>3</volume>(<issue>2</issue>):<fpage>214</fpage>–<lpage>218</lpage>. <ext-link ext-link-type="uri" xlink:href="https://onlinelibrary.wiley.com/doi/abs/10.1002/jcc.540030212">https://onlinelibrary.wiley.com/doi/abs/10.1002/jcc.540030212</ext-link>, doi: <pub-id pub-id-type="doi">10.1002/jcc.540030212</pub-id>.</mixed-citation></ref>
<ref id="c58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schneider</surname> <given-names>T</given-names></string-name>, <string-name><surname>Stoll</surname> <given-names>E.</given-names></string-name></person-group> <article-title>Molecular-dynamics study of a three-dimensional one-component model for distortive phase transitions</article-title>. <source>Phys Rev B Condens Matter</source>. <year>1978</year> <month>Feb</month>; <volume>17</volume>(<issue>3</issue>):<fpage>1302</fpage>–<lpage>1322</lpage>. <ext-link ext-link-type="uri" xlink:href="https://journals.aps.org/prb/abstract/10.1103/PhysRevB.17.1302">https://journals.aps.org/prb/abstract/10.1103/PhysRevB.17.1302</ext-link>, doi: <pub-id pub-id-type="doi">10.1103/PhysRevB.17.1302</pub-id>.</mixed-citation></ref>
<ref id="c59"><mixed-citation publication-type="web"><person-group person-group-type="author"><string-name><surname>Schrödinger</surname> <given-names>L</given-names></string-name>, <string-name><surname>DeLano</surname> <given-names>W</given-names></string-name></person-group>, <source>PyMOL</source>; <year>2020</year>. <ext-link ext-link-type="uri" xlink:href="http://www.pymol.org/pymol">http://www.pymol.org/pymol</ext-link>.</mixed-citation></ref>
<ref id="c60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shi</surname> <given-names>Q</given-names></string-name>, <string-name><surname>Meroueh</surname> <given-names>SO</given-names></string-name>, <string-name><surname>Fisher</surname> <given-names>JF</given-names></string-name>, <string-name><surname>Mobashery</surname> <given-names>S.</given-names></string-name></person-group> <article-title>Investigation of the mechanism of the cell wall DDcarboxypeptidase reaction of penicillin-binding protein 5 of Escherichia coli by quantum mechan-ics/molecular mechanics calculations</article-title>. <source>J Am Chem Soc</source>. <year>2008</year> <month>Jul</month>; <volume>130</volume>(<issue>29</issue>):<fpage>9293</fpage>–<lpage>9303</lpage>. <pub-id pub-id-type="pmid">18576637</pub-id>, doi: <pub-id pub-id-type="doi">10.1021/ja801727k</pub-id>.</mixed-citation></ref>
<ref id="c61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Spagnolo</surname> <given-names>AM</given-names></string-name>, <string-name><surname>Sartini</surname> <given-names>M</given-names></string-name>, <string-name><surname>Cristina</surname> <given-names>ML</given-names></string-name></person-group>. <article-title>Pseudomonas aeruginosa in the healthcare facility setting</article-title>. <source>Reviews in Medical Microbiology</source>. <year>2021</year>; <volume>32</volume>(<issue>3</issue>):<fpage>169</fpage>–<lpage>175</lpage>. doi: <pub-id pub-id-type="doi">10.1097/mrm.0000000000000271</pub-id>.</mixed-citation></ref>
<ref id="c62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tacconelli</surname> <given-names>E</given-names></string-name>, <string-name><surname>Carrara</surname> <given-names>E</given-names></string-name>, <string-name><surname>Savoldi</surname> <given-names>A</given-names></string-name>, <string-name><surname>Harbarth</surname> <given-names>S</given-names></string-name>, <string-name><surname>Mendelson</surname> <given-names>M</given-names></string-name>, <string-name><surname>Monnet</surname> <given-names>DL</given-names></string-name>, <string-name><surname>Pulcini</surname> <given-names>C</given-names></string-name>, <string-name><surname>Kahlmeter</surname> <given-names>G</given-names></string-name>, <string-name><surname>Kluytmans</surname> <given-names>J</given-names></string-name>, <string-name><surname>Carmeli</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Ouellette</surname> <given-names>M</given-names></string-name>, <string-name><surname>Outterson</surname> <given-names>K</given-names></string-name>, <string-name><surname>Patel</surname> <given-names>J</given-names></string-name>, <string-name><surname>Cavaleri</surname> <given-names>M</given-names></string-name>, <string-name><surname>Cox</surname> <given-names>EM</given-names></string-name>, <string-name><surname>Houchens</surname> <given-names>CR</given-names></string-name>, <string-name><surname>Grayson</surname> <given-names>ML</given-names></string-name>, <string-name><surname>Hansen</surname> <given-names>P</given-names></string-name>, <string-name><surname>Singh</surname> <given-names>N</given-names></string-name>, <string-name><surname>Theuretzbacher</surname> <given-names>U</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis</article-title>. <source>Lancet Infect Dis</source>. <year>2018</year>; <volume>18</volume>(<issue>3</issue>):<fpage>318</fpage>–<lpage>327</lpage>. <pub-id pub-id-type="pmid">29276051</pub-id>, doi: <pub-id pub-id-type="doi">10.1016/S1473-3099(17)30753-3</pub-id>.</mixed-citation></ref>
<ref id="c63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Trendelkamp-Schroer</surname> <given-names>B</given-names></string-name>, <string-name><surname>Noe</surname> <given-names>F.</given-names></string-name></person-group> <article-title>Effcient Bayesian estimation of Markov model transition matrices with given stationary distribution</article-title>. <source>J Chem Phys</source>. <year>2013</year>; <volume>138</volume>(<issue>16</issue>):<fpage>164113</fpage>. <pub-id pub-id-type="pmid">23635117</pub-id>, doi: <pub-id pub-id-type="doi">10.1063/1.4801325</pub-id>.</mixed-citation></ref>
<ref id="c64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tripathi</surname> <given-names>R</given-names></string-name>, <string-name><surname>Nair</surname> <given-names>NN</given-names></string-name></person-group>. <article-title>Mechanism of acyl-enzyme complex formation from the Henry-Michaelis complex of class C beta-lactamases with beta-lactam antibiotics</article-title>. <source>J Am Chem Soc</source>. <year>2013</year>; <volume>135</volume>(<issue>39</issue>):<fpage>14679</fpage>–<lpage>90</lpage>. <pub-id pub-id-type="pmid">24010547</pub-id>, doi: <pub-id pub-id-type="doi">10.1021/ja405319n</pub-id>.</mixed-citation></ref>
<ref id="c65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tripathi</surname> <given-names>R</given-names></string-name>, <string-name><surname>Nair</surname> <given-names>NN</given-names></string-name></person-group>. <article-title>Deacylation Mechanism and Kinetics of Acyl-Enzyme Complex of Class C beta-Lactamase and Cephalothin</article-title>. <source>J Phys Chem B</source>. <year>2016</year>; <volume>120</volume>(<issue>10</issue>):<fpage>2681</fpage>–<lpage>90</lpage>. <pub-id pub-id-type="pmid">26918257</pub-id>, doi: <pub-id pub-id-type="doi">10.1021/acs.jpcb.5b11623</pub-id>.</mixed-citation></ref>
<ref id="c66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname> <given-names>W</given-names></string-name>, <string-name><surname>Shi</surname> <given-names>Q</given-names></string-name>, <string-name><surname>Meroueh</surname> <given-names>SO</given-names></string-name>, <string-name><surname>Vakulenko</surname> <given-names>SB</given-names></string-name>, <string-name><surname>Mobashery</surname> <given-names>S.</given-names></string-name></person-group> <article-title>Catalytic mechanism of penicillin-binding protein 5 of Escherichia coli</article-title>. <source>Biochemistry</source>. <year>2007</year> <month>Sep</month>; <volume>46</volume>(<issue>35</issue>):<fpage>10113</fpage>–<lpage>10121</lpage>. <pub-id pub-id-type="pmid">17685588</pub-id>, doi: <pub-id pub-id-type="doi">10.1021/bi700777x</pub-id>.</mixed-citation></ref>
</ref-list>
</back>
<sub-article id="sa0" article-type="editor-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.107688.2.sa3</article-id>
<title-group>
<article-title>eLife Assessment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Allen</surname>
<given-names>Toby W</given-names>
</name>
<role specific-use="editor">Reviewing Editor</role>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-3521-7950</contrib-id>
<aff>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/04ttjf776</institution-id><institution>RMIT University</institution>
</institution-wrap>
<city>Melbourne</city>
<country>Australia</country>
</aff>
</contrib>
</contrib-group>
<kwd-group kwd-group-type="evidence-strength">
<kwd>Incomplete</kwd>
</kwd-group>
<kwd-group kwd-group-type="claim-importance">
<kwd>Valuable</kwd>
</kwd-group>
</front-stub>
<body>
<p>This manuscript uses adaptive-bandit simulations to describe the dynamics of the Pseudomonas-derived chephalosporinase PDC-3 β-lactamase and its mutants to better understand antibiotic resistance. The finding, that clinically observed mutations alter the flexibility of the Ω- and R2-loops, reshaping the cavity of the active site, is <bold>valuable</bold> to the field. The evidence is considered <bold>incomplete</bold>, however, with the need for analysis to demonstrate equilibrium weighting of adaptive trajectories and related measures of statistical significance.</p>
</body>
</sub-article>
<sub-article id="sa1" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.107688.2.sa2</article-id>
<title-group>
<article-title>Reviewer #2 (Public review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>In the manuscript entitled &quot;Ω-Loop mutations control dynamics 2 of the active site by modulating the 3 hydrogen-bonding network in PDC-3 4 β-lactamase&quot;, Chen and coworkers provide a computational investigation of the dynamics of the enzyme Pseudomonas-derived chephalosporinase 3 (PDC3) and some mutants associated with increased antibiotic resistance. After an initial analysis of the enzyme dynamics provided by RMSD/RMSF, the author conclude that the mutations alter the local dynamics within the omega loop and the R2 loop. The authors show that the network of hydrogen bonds in disrupted in the mutants. Constant pH calculations showed that the mutations also change the pKa of the catalytic lysine 67 and pocket volume calculations showed that the mutations expand the catalytic pocket. Finally, time-independent componente analysis (tiCA) showed different profiles for the mutant enzyme as compared to the wild type.</p>
<p>Strengths:</p>
<p>The scope of the manuscript is definitely relevant. Antibiotic resistance is an important problem and, in particular, Pseudomonas aeruginosa resistance is associated with an increasing number of deaths. The choice of the computational methods is also something to highlight here. Although I am not familiar with Adaptive Bandit Molecular Dynamics (ABMD), the description provided in the manuscript that this simulation strategy is well suited for the problem under evaluation.</p>
<p>Weaknesses:</p>
<p>In the revised version, the authors addressed my concerns regarding their use of the MSM, and in my view, their conclusions are now much more robust and well-supported by the data. While it would be very interesting to see a quantitative correlation between the effects of the mutations observed in the MD data and relevant experimental findings, I understand that this may be beyond the scope of the manuscript.</p>
</body>
</sub-article>
<sub-article id="sa2" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.107688.2.sa1</article-id>
<title-group>
<article-title>Reviewer #3 (Public review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>This manuscript aims to explore how mutations in the PDC-3 3 β-lactamase alter its ability to bind and catalyse reactions of antibiotic compounds. The topic is interesting and the study uses MD simulations and to provide hypotheses about how the size of the binding site is altered by mutations that change the conformation and flexibility of two loops that line the binding pocket. Some greater consideration of the uncertainties and how the method choice affect the ability to compare equilibrium properties would strengthen the quantitative conclusions. While many results appear significant by eye, quantifying this and ensuring convergence would strengthen the conclusions.</p>
<p>Strengths:</p>
<p>The significance of the problem is clearly described the relationship to prior literature is discussed extensively.</p>
<p>Comments on revised version:</p>
<p>I am concerned that the authors state in the response to reviews that it is not possible to get error bars on values due to the use of the AB-MD protocol that guides the simulations to unexplored basins. Yet the authors want to compare these values between the WT and mutants. This relates to RMSD, RMSF, % H-bond and volume calculations. I don't accept that you cannot calculate an uncertainty on a time averaged property calculated across the entire simulation. In these cases you can either run repeat simulations to get multiple values on which to do statistical analysis, or you can break the simulation into blocks and check both convergence and calculate uncertainties.</p>
<p>I note that the authors do provide error bars on the volumes, but the statistics given for these need closer scrutiny (I cant test this without the raw data). For example the authors have p&lt;0.0001 for the following pair of volumes 1072 {plus minus} 158 and 1115 {plus minus} 242, or for SASA p&lt;0.0001 is given for 2 identical numbers 155+/- 3.</p>
<p>I also remain concerned about comparisons between simulations run with the AB-MD scheme. While each simulation is an equilibrium simulation run without biasing forces, new simulations are seeded to expand the conformational sampling of the system. This means that by definition the ensemble of simulations does not represent and equilibrium ensemble. For example, the frequency at which conformations are sampled would not be the same as in a single much longer equilibrium simulation. While you may be able to see trends in the differences between conditions run in this way, I still don't understand how you can compare quantitative information without some method of reweighing the ensemble. It is not clear that such a rewieghting exists for this methods, in which case I advise some more caution in the wording of the comparisons made from this data.</p>
<p>At this stage I don't feel the revision has directly addressed the main comments I raised in the earlier review, although there is a stronger response to the comments of Reviewer #2.</p>
</body>
</sub-article>
<sub-article id="sa3" article-type="author-comment">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.107688.2.sa0</article-id>
<title-group>
<article-title>Author response:</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Shuang</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mack</surname>
<given-names>Andrew R</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hujer</surname>
<given-names>Andrea M</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bethel</surname>
<given-names>Christopher R</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bonomo</surname>
<given-names>Robert A</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Haider</surname>
<given-names>Shozeb</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2650-2925</contrib-id></contrib>
</contrib-group>
</front-stub>
<body>
<p>The following is the authors’ response to the current reviews.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #2 (Public review):</bold></p>
<p>Summary:</p>
<p>In the manuscript entitled &quot;Ω-Loop mutations control dynamics 2 of the active site by modulating the 3 hydrogen-bonding network in PDC-3 4 β-lactamase&quot;, Chen and coworkers provide a computational investigation of the dynamics of the enzyme Pseudomonas-derived chephalosporinase 3 (PDC3) and some mutants associated with increased antibiotic resistance. After an initial analysis of the enzyme dynamics provided by RMSD/RMSF, the author conclude that the mutations alter the local dynamics within the omega loop and the R2 loop. The authors show that the network of hydrogen bonds in disrupted in the mutants. Constant pH calculations showed that the mutations also change the pKa of the catalytic lysine 67 and pocket volume calculations showed that the mutations expand the catalytic pocket. Finally, time-independent componente analysis (tiCA) showed different profiles for the mutant enzyme as compared to the wild type.</p>
<p>Strengths:</p>
<p>The scope of the manuscript is definitely relevant. Antibiotic resistance is an important problem and, in particular, Pseudomonas aeruginosa resistance is associated with an increasing number of deaths. The choice of the computational methods is also something to highlight here. Although I am not familiar with Adaptive Bandit Molecular Dynamics (ABMD), the description provided in the manuscript that this simulation strategy is well suited for the problem under evaluation.</p>
<p>Weaknesses:</p>
<p>In the revised version, the authors addressed my concerns regarding their use of the MSM, and in my view, their conclusions are now much more robust and well-supported by the data. While it would be very interesting to see a quantitative correlation between the effects of the mutations observed in the MD data and relevant experimental findings, I understand that this may be beyond the scope of the manuscript.</p>
</disp-quote>
<p>Thank you for the careful evaluation and constructive comments. Regarding the suggestion of a more quantitative correlation with experimental observables, we agree that this would be valuable, and we have noted it as an important direction for future work.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #3 (Public review):</bold></p>
<p>Summary:</p>
<p>This manuscript aims to explore how mutations in the PDC-3 3 β-lactamase alter its ability to bind and catalyse reactions of antibiotic compounds. The topic is interesting and the study uses MD simulations and to provide hypotheses about how the size of the binding site is altered by mutations that change the conformation and flexibility of two loops that line the binding pocket. Some greater consideration of the uncertainties and how the method choice affect the ability to compare equilibrium properties would strengthen the quantitative conclusions. While many results appear significant by eye, quantifying this and ensuring convergence would strengthen the conclusions.</p>
<p>Strengths:</p>
<p>The significance of the problem is clearly described the relationship to prior literature is discussed extensively.</p>
<p>Comments on revised version:</p>
<p>I am concerned that the authors state in the response to reviews that it is not possible to get error bars on values due to the use of the AB-MD protocol that guides the simulations to unexplored basins. Yet the authors want to compare these values between the WT and mutants. This relates to RMSD, RMSF, % H-bond and volume calculations. I don't accept that you cannot calculate an uncertainty on a time averaged property calculated across the entire simulation. In these cases you can either run repeat simulations to get multiple values on which to do statistical analysis, or you can break the simulation into blocks and check both convergence and calculate uncertainties.</p>
</disp-quote>
<p>We thank the reviewer for raising this point. We would like to clarify that we did not intend to state that error bars are impossible to obtain under AB-MD. In fact, we reported error bars for several quantities derived from the AB-MD trajectories (we also broke the trajectories into blocks and calculated uncertainties for RMSF in our first-round response as you suggested). However, these data are closely related to your concern about comparing quantitative information without an appropriate reweighting of the ensemble. Therefore, in the revised manuscript, we removed quantitative analyses that were calculated directly from the raw AB-MD trajectories. Instead, the quantitative comparisons are now obtained from MSM analysis. We report pocket volumes and key interaction metrics for MSM metastable states, with corresponding error bars for these MSM-based quantities (Figure 6 and its supplementary figure).</p>
<disp-quote content-type="editor-comment">
<p>I note that the authors do provide error bars on the volumes, but the statistics given for these need closer scrutiny (I cant test this without the raw data). For example the authors have p&lt;0.0001 for the following pair of volumes 1072 {plus minus} 158 and 1115 {plus minus} 242, or for SASA p&lt;0.0001 is given for 2 identical numbers 155+/- 3.</p>
</disp-quote>
<p>Thank you for this comment. As noted above, we have removed the table from the manuscript, and the pocket-volume results together with their error bars are now shown in Figure 6. To address the concern raised here and to avoid making the same mistake in future analyses, we re-examined how the statistics were computed. We believe the very small p-values were caused by treating per-frame MD values as independent observations in two-sample t-tests. Because consecutive MD frames are strongly time-correlated, they do not satisfy the independence assumption, which can greatly overestimate the effective sample size and lead to artificially small p-values. For the SASA, a p &lt; 0.0001 is reported even though both values are shown as 155 ± 3. This is due to rounding, which can hide subtle underlying differences.</p>
<disp-quote content-type="editor-comment">
<p>I also remain concerned about comparisons between simulations run with the AB-MD scheme. While each simulation is an equilibrium simulation run without biasing forces, new simulations are seeded to expand the conformational sampling of the system. This means that by definition the ensemble of simulations does not represent and equilibrium ensemble. For example, the frequency at which conformations are sampled would not be the same as in a single much longer equilibrium simulation. While you may be able to see trends in the differences between conditions run in this way, I still don't understand how you can compare quantitative information without some method of reweighing the ensemble. It is not clear that such a rewieghting exists for this methods, in which case I advise some more caution in the wording of the comparisons made from this data.</p>
<p>At this stage I don't feel the revision has directly addressed the main comments I raised in the earlier review, although there is a stronger response to the comments of Reviewer #2.</p>
</disp-quote>
<p>We thank the reviewer for reiterating this important point, and we agree with the underlying concern. Although AB-MD generates unbiased trajectories, the ensemble of simulations does not represent an equilibrium ensemble. As a result, statistics computed by simply concatenating all AB-MD trajectories should not be used for quantitative comparisons. In the original version, we acknowledge that we reported several quantitative descriptors directly from concatenated AB-MD frames, including (i) distributions of χ1 torsions, (ii) mean pocket volumes and SASA, and (iii) percentages of some key interactions. We agree that this was not appropriate given the adaptive sampling protocol. In the revised manuscript, we have removed these quantitative analyses.</p>
<p>We retained RMSD and RMSF analyses, but we have revised their wording and clarified their purpose. RMSD and RMSF are used only to summarize the structural variability and residue-level mobility observed across the collected trajectory segments and to motivate the selection of structural features for MSM construction. The manuscript now states: “Because AB-MD adaptively seeds new unbiased trajectories to expand conformational sampling, RMSD and RMSF are used here to summarize the structural variability and per-residue mobility observed across the collected trajectories.”</p>
<p>Regarding the reviewer’s question about reweighting, the Markov state model (MSM) provides a principled framework to obtain the stationary distribution <italic>π</italic> from the transition probability matrix <italic>T<sub>τ</sub></italic>. The resulting <italic>π<sub>i</sub></italic> gives the equilibrium weight of each microstate <italic>i</italic>, and the corresponding discrete free energy can be written as <italic>F<sup>i</sup></italic>=−<italic>k</italic><sub>B</sub><italic>T</italic>ln(<italic>π<sub>i</sub></italic>). PCCA then coarse-grains the microstate space into a small number of metastable states. In the revised manuscript, quantitative comparisons are therefore derived from the MSM at the level of these metastable states, rather than from unweighted counts of concatenated AB-MD frames.</p>
<p>Accordingly, we have revised the sections “E219K and Y221A mutations facilitate proton transfer” and “Substitutions enlarge the active-site pocket to accommodate bulkier R1 and R2 groups of β-lactams”, and we have added new figures in Figure 6 and its figure supplement. The adjustments to the quantitative analyses do not affect our original conclusions.</p>
<p>The following is the authors’ response to the original reviews.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #1</bold> (<bold>Public review)</bold>:</p>
<p>Summary:</p>
<p>This manuscript uses adaptive sampling simulations to understand the impact of mutations on the specificity of the enzyme PDC-3 β-lactamase. The authors argue that mutations in the Ω-loop can expand the active site to accommodate larger substrates.</p>
<p>Strengths:</p>
<p>The authors simulate an array of variants and perform numerous analyses to support their conclusions. The use of constant pH simulations to connect structural differences with likely functional outcomes is a strength.</p>
<p>Weaknesses:</p>
<p>I would like to have seen more error bars on quantities reported (e.g., % populations reported in the text and Table 1).</p>
</disp-quote>
<p>We appreciate this point. Here, the population we analyze is intended to showcase conformational differences across variants rather than to estimate equilibrium occupancies. Although each system includes 100 trajectories, they were generated using an adaptive-bandit protocol. The protocol deliberately guides towards underexplored basins, therefore conformational heterogeneity betweentrajectories is expected by design. For example, in E219K the MSM decomposition shows that in states 1, 6, and 7 the K67(NZ)–S64(OG) distance is almost entirely &gt; 6 Å, whereas in states 2 and 3 it is almost entirely &lt; 3.5 Å (Figure 5—figure supplement 12). These distances suggest that the hydrogen bond fraction is approximately zero in states 1, 6, and 7, and close to one in states 2 and 3. In addition, the mean first passage time of the Markov state models suggests that the formation and disruption of this hydrogen bond occur on the microsecond timescale, which is far longer than the length of each individual trajectory (300 ns). Consequently, across the 100 replicas, some trajectories exhibit very low fractions, while others display the opposite trend. Under such bimodal, protocol-induced heterogeneity, computing an error bar across trajectories mainly visualizes the protocol’s dispersion and risks being misread as thermodynamic uncertainty, which is not central to our aim of comparing conformational differences between wild-type PDC-3 and variants. We therefore do not include the error bars.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #2</bold> (<bold>Public review)</bold>:</p>
<p>Summary:</p>
<p>In the manuscript entitled &quot;Ω-Loop mutations control dynamics of the active site by modulating the 3 hydrogen-bonding network in PDC-3 4 β-lactamase&quot;, Chen and coworkers provide a computational investigation of the dynamics of the enzyme Pseudomonas-derived cephalosporinase 3 (PDC3) and some mutants associated with increased antibiotic resistance. After an initial analysis of the enzyme dynamics provided by RMSD/RMSF, the author concludes that the mutations alter the local dynamics within the omega loop and the R2 loop. The authors show that the network of hydrogen bonds is disrupted in the mutants. Constant pH calculations showed that the mutations also change the pKa of the catalytic lysine 67, and pocket volume calculations showed that the mutations expand the catalytic pocket. Finally, time-independent component analysis (tiCA) showed different profiles for the mutant enzyme as compared to the wild type.</p>
<p>Strengths:</p>
<p>The scope of the manuscript is definitely relevant. Antibiotic resistance is an important problem, and, in particular, Pseudomonas aeruginosa resistance is associated with an increasing number of deaths. The choice of the computational methods is also something to highlight here. Although I am not familiar with Adaptive Bandit Molecular Dynamics (ABMD), the description provided in the manuscript suggests that this simulation strategy is well-suited for the problem under evaluation.</p>
<p>Weaknesses:</p>
<p>In the description of many of their results, the authors do not provide enough information for a deep understanding of the biochemistry/biophysics involved. Without these issues addressed, the strength of the evidence is of concern.</p>
</disp-quote>
<p>We thank the reviewer for pointing out the need for deeper discussion of the biochemical and biophysical implications of our results. In our manuscript, we begin by examining basic structural metrics (e.g., RMSD and RMSF) which clearly indicate that the major conformational changes occur in the Ω-loop and the R2 loop. We have now added a paragraph to describe the importance of the Ωloop and highlighted it in the revised manuscript on lines 142-166 of page 6. This observation guided our subsequent focus on these regions, as well as on the catalytic site. Our analysis revealed notable alterations in the hydrogen bonding network—especially in interactions involving the K67-S64, K67N152, K67-G220, Y150-A292, and N287-N314 pairs. These observations led us to conclude that:</p>
<p>(1) Mutations E219K and Y221A facilitate the proton transfer of catalytic residues. This is consistent with prior experimental data showing that these substitutions produce the most pronounced increase in sensitivity to cephalosporin antibiotics (lines 210-212 in page 8 of the revised manuscript).</p>
<p>(2) Substitutions enlarge the active-site pocket to accommodate bulkier R1 and R2 groups of β-lactams.This is in line with MIC measurements reported by Barnes et al. (2018), which showed that mutants with larger active-site pockets exhibit markedly greater sensitivity to cephalosporins with bulky side chains than others (lines 249-259 in pages 10).</p>
<p>Furthermore, we applied Markov state models (MSMs) to explore the timescales of the transitions between these different conformational states. We believe that these methodological steps support our conclusions.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #3</bold> (<bold>Public review)</bold>:</p>
<p>Summary:</p>
<p>This manuscript aims to explore how mutations in the PDC-3 3 β-lactamase alter its ability to bind and catalyse reactions of antibiotic compounds. The topic is interesting, and the study uses MD simulations to provide hypotheses about how the size of the binding site is altered by mutations that change the conformation and flexibility of two loops that line the binding pocket. However, the study doesn't clearly describe the way the data is generated. While many results appear significant by eye, quantifying this and ensuring convergence would strengthen the conclusions.</p>
<p>Strengths:</p>
<p>The significance of the problem is clearly described, and the relationship to prior literature is discussed extensively.</p>
<p>Weaknesses:</p>
<p>The methods used to gain the results are not explained clearly, meaning it was hard to determine exactly how some data was obtained. The convergence and uncertainties in the data were not adequately quantified. The text is also a little long, which obscures the main findings.</p>
</disp-quote>
<p>We thank the reviewer for the suggestion. We respectfully ask the reviewer to specify which aspects of the data-generation methods are unclear so that we can include the necessary details in the next revision. Moreover, all statistics that are reported in the manuscript are obtained from extensive analyses of 300,000 simulation frames. The Markov state models have been validated by the ITS plots and Chapman-Kolmogorov (CK) test. The two-sample t-tests were also carried out for the volume and SASA.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #2 (Recommendations for the authors)</bold>:</p>
<p>(1) Figure 1D focus on the PDC3 catalytic site. However, the authors mentioned before that the enzyme has two domains, an alpha domain and an alpha/beta domain. The reader would benefit from a more detailed description of the enzyme, its active site, AND the location of the mutants under investigation in the figure.</p>
</disp-quote>
<p>We have updated Figure 1D and marked the positions of all mutations (V211A/G, G214A/R, E219A/G/K and Y221A/H), which have now been highlighted as spheres.</p>
<disp-quote content-type="editor-comment">
<p>(2) Since in the journal format, the results come before the methods. It would be interesting to add a brief description of where the results came from. For example, in the first section of the results, the authors describe the flexibility of the omega loop and the R2 loop. However, the reader won't know what kind of simulation was used and for how long, for example. A sentence would add the required context for a deeper understanding here.</p>
</disp-quote>
<p>At the beginning of the Results and Discussion section we now state: “To investigate how the mutations in the Ω-loop affect PDC-3 dynamics, adaptive-bandit molecular dynamics (AB-MD) simulations were carried out for each system. 100 trajectories of 300 ns each (totaling 30 μs per system) were run.”</p>
<disp-quote content-type="editor-comment">
<p>(3) Still in the same section, the authors don't define what change in RMSF is considered significant. For example, I can't see a relevant change in the RMSF for the omega loop between the et enzyme and the E219 mutants in Figure 2D. A more objective definition would be of benefit here.</p>
</disp-quote>
<p>Our analysis reveals that while the wild-type PDC-3 and the G214A, G214R, E214G, and Y221A variants exhibit an average per-residue RMSF of around 4 Å in the Ω-loop, the V211A and V211G variants show markedly lower values (around 1.5 Å), and the E219K and Y221H variants exhibit intermediate values between 2 and 2.5 Å. In addition, the fluctuations around the binding site should be seen collectively along with the fluctuations in the R2-loop. Importantly, we urge the reviewer to focus on the MDLovofit analysis in Figure 2C, where the dynamic differences between the core and the fluctuating loops is clearly evident.</p>
<disp-quote content-type="editor-comment">
<p>(4) In line 138, the authors state that &quot;Therefore, the flexibility of these proteins is mainly caused by the fluctuations in the Ω-loops and R2-loop&quot;. This is quite a bold statement to be drawn at this point. First of all, there is no mention of it in the manuscript, but is there any domain movement? Figure 2C clearly shows that there is some mobility in omega and R2 loops. But there is no evidence shown in the manuscript that shows that &quot;the flexibility of these proteins is mainly caused by the fluctuations in the&quot; loops. Please consider rephrasing this sentence or adding more data, if available.</p>
</disp-quote>
<p>We have revised the wording to take the reviewer’s concern into account. The sentence now states: “Therefore, flexibility of PDC-3 is predominantly localized to the Ω- and R2-loops, whereas the remainder of the structure is comparatively rigid.” To further explain to the reviewer, the β lactamase enzymes are fairly rigid structures, where no large-scale domain motions occur. Instead, the enzyme communicates structurally via cross correlation of loop dynamics ( <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.7554/eLife.66567">https://doi.org/10.7554/eLife.66567</ext-link> ).</p>
<disp-quote content-type="editor-comment">
<p>(5) I guess, the most relevant question for the scope of the paper is not answered in this section. The authors show that the mobility of the omega- and R2-loops is altered by some mutations. Why is that? I wish I could see a figure showing where the mutations are and where the loops are. This question will come back in other sections.</p>
</disp-quote>
<p>We have updated Figure 1D to mark the positions of all mutations (V211A/G, G214A/R, E219A/G/K and Y221A/H) as spheres. The Ω- and R2-loops are also highlighted. All mutations map to the Ω-loop, indicating that these substitutions directly perturb this region. Notably, K67 forms a hydrogen bond with the backbone of G220 within the Ω-loop and another with the phenolic hydroxyl of Y150. Y150, in turn, hydrogen-bonds with A292 in the R2 loop. Together, the residue interaction network (G220– K67–Y150–A292) suggest a pathway by which Ω-loop mutations propagate their effects to the R2 loop.</p>
<disp-quote content-type="editor-comment">
<p>(6) The authors then analyze the network of polar residues in the active site and the hydrogen bonds observed there. For the K67-N152 hydrogen bond, for example, there is a reduction in the occupancy from ~70% in the wild-type enzyme to ~30% and 40% in the mutants E219K and Y221, respectively. This finding is interesting. The question that remains is &quot;why is that&quot;? From the structural point of view, how does the replacement of E219 with a Lysine alter the hydrogen bond formation between K67 and N152? Is it due to direct competition? Solvent rearrangement? The reader is left without a clue in this section. Also, Figure 3B won't help the reader, since the mutated residues are not shown there. Please consider adding some information about why the authors believe that the mutations are disrupting the active site hydrogen bond network and showing it in Figure 3B.</p>
</disp-quote>
<p>We appreciate the comment and have updated Figures 1D and 3B to highlight the mutation sites. The change from ~70% in the wild type to ~30–40% in the E219K and Y221T variants reported in Table 1 refers to the S64–K67 hydrogen bond. In the wild type, K67 forms an additional hydrogen bond with G220 on the Ω-loop, which helps anchor the K67 side chain in a geometry that favors the S64–K67 interaction. In the variants, the mutations reshape the Ω-loop and frequently disrupt the K67–G220 contact. The loss of this local anchor increases the conformational dispersion of K67, which is consistent with the observed reduction of the S64–K67 occupancy. Furthermore, our observation that the mutations are disrupting the active-site hydrogen-bond network is a data-driven conclusion rather than a subjective inference. Across ten systems, our AB-MD simulations provided 30 µs of sampling per system. Saving one frame every nanosecond yielded 30,000 conformations per system and 300,000 in total. All hydrogen-bond and salt-bridge statistics were computed over this full ensemble. Thus, the conclusion that the mutations disrupt the active-site hydrogen-bond network follows directly from these ensemble statistics.</p>
<disp-quote content-type="editor-comment">
<p>(7) The pKa calculations and the pocket volume calculations show that the mutations expand the volume of the catalytic site and alter the microenvironment. Is there any change in the solvation associated with these changes? If the volume expands and the environment becomes more acidic, are there more water molecules in the mutants as compared to the wt enzyme? If so, can changes in solvation be associated with the changes in the hydrogen bond network? Would a simulation in the presence of a substrate be meaningful here? ( I guess it would!).</p>
</disp-quote>
<p>Regarding solvation, we observe a modest increase in transient water occupancy associated with the increase in volume of the pocket. The conserved deacylation water molecule is the most important and is always present throughout the simulation. Additional waters enter and leave the pocket but do not form persistent interactions that measurably perturb the hydrogen-bond network of the Ω- and R2-loops. We agree that simulations with a bound substrate would be informative. However, our study focuses on how Ω-loop mutations modulate the active site of apo PDC-3 and its variants. Within this scope, we find: (i) Amino acid substitutions change the flexibility of Ω-loops and R2-loops; (ii) E219K and Y221A mutations facilitate the proton transfer; (iii) Substitutions enlarge the active-site pocket to accommodate bulkier R1 and R2 groups of β-lactams.</p>
<disp-quote content-type="editor-comment">
<p>(8) I have some concerns regarding the Markov State Modeling as shown here. After a time-independent component analysis, the authors show the projections on the components, which is different between wild wild-type enzyme and the mutants, and draw some conclusions from these changes. For example, the authors state that &quot;From the metastable state results, we observe that E219K adopts a highly stable conformation in which all the tridentate hydrogen-bonding interactions (K67(NZ)-S64(OG), K67(NZ)N152(OD1) and K67(NZ)-G220(O) mentioned above are broken&quot;. This is conclusion is very difficult to draw from Figure 5 alone. Unless the macrostates observed in the MSM can be shown (their structures) and could confirm the broken interactions, I really don't believe that the reader can come to the same conclusion as drawn by the authors here. I would recommend the authors to map the macrostates back to the coordinates and show them (what structure corresponds to what macrostate). After showing that, it makes sense to discuss what macrostate is being favored by what mutation. Taking conclusions from tiCA projections only is not recommended. I very strongly suggest that the authors revisit this entire section, adding more context so that the reader can draw conclusions from the data that is shown.</p>
</disp-quote>
<p>We appreciate the reviewer’s concern. In the Markov state modeling section, our objective is to quantify the timescales (via mean first passage times) associated with the formation and disruption of the critical hydrogen bonds (K67(NZ)-S64(OG), K67(NZ)-N152(OD1), K67(NZ)-G220(O), Y150(N)A292(O), N287(ND2)-N314(OD1)) mentioned above. Representative structures illustrating these interactions are shown in Figures 3B and 4A. We agree that the main Figure 5 alone does not convey structural information. Accordingly, we provide Figure 5—figure supplements 12–16. Together, Figure 5B and Figure 5—figure supplements 12–16 map structures to metastable states, whereas Figures 3B and 4A supply atomistic detail of the interactions. Author response image 1 presents selected subplots from Figure 5— figure supplements 12–14. Together with the free-energy landscape in Figure 5A, these data indicate that E219K adopts a highly stable conformation in which all three K67-centered hydrogen bonds (K67(NZ)–S64(OG), K67(NZ)–N152(OD1), and K67(NZ)–G220(O)) are broken.</p>
<fig id="sa3fig1">
<label>Author response image 1.</label>
<caption>
<title>TICA plot illustrates the distribution of E219K with the colour indicating the K67(NZ)-S64(OG), K67(NZ)-N152(OD1) and K67(NZ)-G220(O) distance.</title>
</caption>
<graphic mime-subtype="jpg" xlink:href="elife-107688-sa3-fig1.jpg" mimetype="image"/>
</fig>
<disp-quote content-type="editor-comment">
<p>(9) As a very minor issue, there are a few typos in the manuscript text. The authors might want to take some time to revisit their entire text. Examples in lines 70, 197, etc.</p>
</disp-quote>
<p>Thank you for your comment. We have corrected these typos.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #3 (Recommendations for the authors)</bold>:</p>
<p>This manuscript aims to explore how mutations in the PDC-3 3 β-lactamase alter its ability to bind and catalyse reactions of antibiotic compounds. The topic is interesting, and the study uses MD simulations to provide hypotheses about how the size of the binding site is altered by mutations that change the conformation and flexibility of two loops that line the binding pocket.</p>
<p>However, the study doesn't clearly describe the way the data is generated and potentially lacks statistical rigour, which makes it uncertain if the key results are significant. As such, it is difficult to judge if the conclusions made are supported by data.</p>
</disp-quote>
<p>All necessary data-acquisition methods are described in the Methods section. The Markov state models have been validated by the ITS plot and the Chapman-Kolmogorov (CK) test (Figure 5—figure supplement 2–11) . The two-sample t-tests were also carried out for the volume and SASA (Table 2).</p>
<disp-quote content-type="editor-comment">
<p>The results section jumps straight to reporting RMSD and RMSF values; however, it is not clear what simulations are used to generate this information. Indeed, the main text does not mention the simulations themselves at all. The methods section mentions that 10 independent MD simulations were set up for each system, but no information is given as to how long these were run or the equilibration protocol used. Then it says that AB-MD simulations were run, but it is not clear what starting coordinates were used for this or how the 10 replicates were fed into these simulations. Most importantly, are the RMSD and RMSF calculations and later distance distribution information derived from the equilibrium MD runs or from the AB-MD simulations?</p>
</disp-quote>
<p>Thank you for pointing this out. We have added “To investigate how the mutations in the Ω-loop affect PDC-3 dynamics, adaptive-bandit molecular dynamics (AB-MD) simulations were carried out for each system. 100 trajectories of 300 ns each (totaling 30 μs per system) were run.” to the Results and Discussion section. We didn’t run 10 independent MD simulations per system. We regret the typo in the Methods section that confused the reviewer. The sentence should have read – ‘All-atom MD simulations of wild-type PDC-3 and its variants were performed.’ Each system was equilibrated for 5 ns at 1 atmospheric pressure using Berendsen barostat. AB-MD simulations were initiated from these equilibrated structures. All analyses, apart from CpHMD, are based on the AB-MD trajectories.</p>
<disp-quote content-type="editor-comment">
<p>If these are taken from the equilibrium simulations, then it is critical that the reproducibility and statistical significance of the simulations is established. This can be done by calculating the RMSD and RMSF values independently for each replicate and determining the error bars. From this, the significance of differences between WT and mutant simulations can be determined. Without this, I have no data to judge if the main conclusions are supported or not. If these are derived from the AB-MD simulations, then I want to know how the independent simulations were combined and reweighted to generate overall RMSD, RMSF, and distance distributions. Unless I misunderstand the approach, the individual simulations no longer sample all regions of conformational space the same relative amount you would see in a standard MD simulation - specific conformational regions are intentionally run more to enhance sampling, then the overall conformational distributions cannot be obtained from these simulations without some form of reweighting scheme. But no such scheme is described. In addition, convergence of the data is required to ensure that the RMSD, RMSF, and distances have reached stable values. It is possible that I am misunderstanding the approach here. But in that case, I hope the authors can clarify the method and provide a means of ensuring that the data presented is converged. Many of the differences are clear by eye, but it is important to know they are not random differences between simulations and rather reflect differences between them.</p>
</disp-quote>
<p>Thank you for raising this important point. In our AB-MD workflow, the adaptive bandit is used only for starting-structure selection (adaptive seeding). After each epoch, it chooses new starting snapshots from previously sampled conformations and launches the next runs. Each trajectory itself is standard, unbiased MD with no biasing potentials and no modification of the Hamiltonian. In other words, AB decides where we start, but does not alter the physics or sampling dynamics within an individual trajectory. In addition, our goal in this work is to compare variants under the same adaptive-bandit (AB) protocol, rather than to estimate equilibrium (Boltzmann) populations. Hence, we did not apply equilibrium reweighting to RMSD, RMSF, or distance distributions. However, MSM section provides reweighted reference results based on the MSM stationary distribution.</p>
<disp-quote content-type="editor-comment">
<p>In the response to reviews, the authors state that the &quot;RMSF is a statistical quantity derived from averaging the time series of atomic displacements, resulting in a fixed value without an inherent error bar.&quot; But normally we would run multiple replicates and get an error bar from the different values in each. To dismiss the request for uncertainties and error bars seems to miss the point. I strongly agree with the prior reviewer that comparisons between RMSF or other values should be accompanied by uncertainties and estimates of statistical significance.</p>
</disp-quote>
<p>Regarding the reviewers’ suggestion to present the data as a bar graph with error bars, we would like to note that RMSF is calculated as the time average of the fluctuations of each residue’s Cα atom over the entire simulation. As such, RMSF is a statistical quantity derived from averaging the time series of atomic displacements, resulting in a fixed value without an inherent error bar. We believe that our current presentation clearly and accurately reflects the local flexibility differences among the variants. Nearly all published studies report RMSF in this way, as indicated by the following examples:</p>
<p>Figure 3a in DOI: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1021/jacsau.2c00077">https://doi.org/10.1021/jacsau.2c00077</ext-link></p>
<p>Figure 2 in DOI: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1021/acs.jcim.4c00089">https://doi.org/10.1021/acs.jcim.4c00089</ext-link></p>
<p>Supplementary Fig. 1, 2, 5, 9, 12, 20, 22, 24, and 26 in DOI: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/s41467-022-293313">https://doi.org/10.1038/s41467-022-293313</ext-link></p>
<p>However, in response to the reviewers’ strong request, we present RMSF plots with error bars in our response letter.</p>
<fig id="sa3fig2">
<label>Author response image 2.</label>
<caption>
<title>The root-mean-square fluctuation (RMSF) profiles of wild-type PDC-3 and its variants.</title>
<p>Blue lines show the mean RMSF across 100 independent MD trajectories for each system; red translucent bands denote the standard deviation across trajectories. The Ω-loop (residues G183 to S226) is highlighted in yellow, and the R2-loop (residues L280 to Q310) is highlighted in blue.</p>
</caption>
<graphic mime-subtype="jpg" xlink:href="elife-107688-sa3-fig2.jpg" mimetype="image"/>
</fig>
<disp-quote content-type="editor-comment">
<p>It was good to see that convergence of the constant-pH simulations was shown. While it can be challenging to get absolute pH values from the implicit solvent-based simulations, the differences between the systems are large and the trends appear significant. I was not clear how the starting coordinates were chosen for these simulations. Is the end point of the classical simulations, or is a representative snapshot chosen somehow?</p>
</disp-quote>
<p>To ensure comparison, all systems used the X-ray crystal structure (PDB ID: 4HEF) with T79A substitution as the initial structure. The E219K and Y221A mutants were generated in silico using the ICM mutagenesis module. We have added the clarification in Methods section: “The starting structures were identical to those used for AB-MD.”</p>
<disp-quote content-type="editor-comment">
<p>Significant figures: Throughout the text and tables, the authors present data with more figures than are significant. 1071.81+-157.55 should be reported as 1100 +/ 160 or 1070 =- 160 . See the eLife guidelines for advice on this.</p>
</disp-quote>
<p>Thank you for your suggestion. We have amended these now.</p>
<disp-quote content-type="editor-comment">
<p>The manuscript is very long for the results presented, and I feel that a clearer story would come across if the authors shortened the text so that the main conclusions and results were not lost.</p>
</disp-quote>
<p>We appreciate the suggestion. We examined the twenty most recent research articles published in eLife and found that they are either longer than or comparable in length to our manuscript.</p>
</body>
</sub-article>
</article>